0001602078 2022-04-01 2023-03-31 0001602078 2023-03-31 0001602078 2022-03-31 0001602078 2021-04-01 2022-03-31 0001602078 us-gaap:CommonStockMember 2021-03-31 0001602078 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001602078 us-gaap:RetainedEarningsMember 2021-03-31 0001602078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001602078 2021-03-31 0001602078 us-gaap:CommonStockMember 2022-03-31 0001602078 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001602078 us-gaap:RetainedEarningsMember 2022-03-31 0001602078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001602078 us-gaap:CommonStockMember 2021-04-01 2022-03-31 0001602078 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2022-03-31 0001602078 us-gaap:RetainedEarningsMember 2021-04-01 2022-03-31 0001602078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2022-03-31 0001602078 us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001602078 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2023-03-31 0001602078 us-gaap:RetainedEarningsMember 2022-04-01 2023-03-31 0001602078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2023-03-31 0001602078 us-gaap:CommonStockMember 2023-03-31 0001602078 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001602078 us-gaap:RetainedEarningsMember 2023-03-31 0001602078 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001602078 currency:USD 2023-03-31 0001602078 currency:USD 2022-03-31 0001602078 currency:GBP 2023-03-31 0001602078 currency:GBP 2022-03-31 0001602078 currency:EUR 2023-03-31 0001602078 currency:EUR 2022-03-31 0001602078 nmrd:WarrantsMember 2023-03-31 0001602078 nmrd:WarrantsMember 2022-03-31 0001602078 nmrd:StockOptionsMember 2023-03-31 0001602078 nmrd:StockOptionsMember 2022-03-31 0001602078 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001602078 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001602078 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001602078 us-gaap:FairValueInputsLevel12And3Member 2023-03-31 0001602078 us-gaap:FairValueInputsLevel1Member 2022-03-31 0001602078 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001602078 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001602078 us-gaap:FairValueInputsLevel12And3Member 2022-03-31 0001602078 us-gaap:FairValueInputsLevel3Member 2022-04-01 2023-03-31 0001602078 us-gaap:PatentsMember 2023-03-31 0001602078 us-gaap:PatentsMember 2022-03-31 0001602078 us-gaap:PatentsMember 2022-04-01 2023-03-31 0001602078 us-gaap:PatentsMember 2021-04-01 2022-03-31 0001602078 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-03-31 0001602078 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-03-31 0001602078 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-04-01 2023-03-31 0001602078 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-04-01 2022-03-31 0001602078 2023-01-01 2023-01-31 0001602078 us-gaap:WarrantMember 2022-04-01 2023-03-31 0001602078 us-gaap:WarrantMember 2023-01-30 2023-01-31 0001602078 nmrd:NotePurchaseAgreement1Member 2023-03-31 0001602078 nmrd:NotePurchaseAgreement1Member 2022-03-31 0001602078 nmrd:NotePurchaseAgreement2Member 2023-03-31 0001602078 nmrd:NotePurchaseAgreement2Member 2022-03-31 0001602078 nmrd:NotePurchaseAgreement3Member 2023-03-31 0001602078 nmrd:NotePurchaseAgreement3Member 2022-03-31 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement1Member 2020-04-15 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement1Member 2020-04-14 2020-04-15 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2021-02-08 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2021-02-07 2021-02-08 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2022-02-01 2022-02-28 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2022-04-30 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2022-05-31 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2022-10-01 2022-10-31 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2022-10-31 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2023-03-31 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement2Member 2022-04-01 2023-03-31 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement3Member 2022-05-20 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement3Member 2022-05-19 2022-05-20 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement3Member 2021-02-08 0001602078 nmrd:SecuredNoteMember us-gaap:InvestorMember nmrd:NotePurchaseAgreement3Member 2023-03-31 0001602078 country:US 2022-04-01 2023-03-31 0001602078 country:US 2021-04-01 2022-03-31 0001602078 country:GB 2022-04-01 2023-03-31 0001602078 country:US 2023-03-31 0001602078 country:GB 2023-03-31 0001602078 2022-03-24 0001602078 us-gaap:CommonStockMember nmrd:ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember 2023-01-01 2023-01-31 0001602078 us-gaap:CommonStockMember nmrd:ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember 2023-01-31 0001602078 us-gaap:WarrantMember nmrd:ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember 2023-01-01 2023-01-31 0001602078 us-gaap:WarrantMember nmrd:ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember 2023-01-31 0001602078 nmrd:ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember 2023-01-01 2023-01-31 0001602078 nmrd:MarketOfferingAgreementMember nmrd:HCWainwrightAndCoLLCMember 2021-04-02 0001602078 nmrd:AtTheMarketofferingAgreementMember 2021-04-01 2022-03-31 0001602078 nmrd:TigerTradingPartnersLLCMember 2021-04-01 2022-03-31 0001602078 nmrd:AtTheMarketofferingAgreementMember 2022-03-31 0001602078 nmrd:TigerManagementLLCMember 2021-04-01 2022-03-31 0001602078 nmrd:TigerManagementLLCMember 2022-03-31 0001602078 nmrd:ATMFacility2021Member 2021-04-01 2022-03-31 0001602078 nmrd:ATMFacility2021Member 2022-02-09 2022-02-10 0001602078 nmrd:BoardOfDirectorsMember us-gaap:CommonStockMember 2022-01-27 2022-01-28 0001602078 nmrd:BoardOfDirectorsMember us-gaap:CommonStockMember 2022-01-28 0001602078 us-gaap:StockOptionMember 2021-03-31 0001602078 us-gaap:StockOptionMember 2021-04-01 2022-03-31 0001602078 us-gaap:StockOptionMember 2022-03-31 0001602078 us-gaap:StockOptionMember 2022-04-01 2023-03-31 0001602078 us-gaap:StockOptionMember 2023-03-31 0001602078 us-gaap:WarrantMember 2021-03-31 0001602078 us-gaap:WarrantMember 2020-04-01 2021-03-31 0001602078 us-gaap:WarrantMember 2021-04-01 2022-03-31 0001602078 us-gaap:WarrantMember 2022-03-31 0001602078 us-gaap:WarrantMember 2023-03-31 iso4217:USD shares iso4217:USD shares iso4217:GBP pure 0001602078 true POS AM Nemaura Medical, Inc. NV Non-accelerated Filer true false The registrant is filing this post-effective amendment to update the financial statements and other information contained in the registrants’ registration statement on Form S-1 (Registration No. 333-270511) (the “Registration Statement”), which was declared effective by the Securities and Exchange Commission on May 12, 2023. The Registration Statement relates to the sale of up to 4,796,206 shares of common stock, $0.001 par value per share, by two selling stockholders identified in the prospectus. As of August 3, 2023, no shares of common stock have been sold pursuant to the Registration Statement. No additional securities are being registered pursuant to this post-effective amendment to the Registration Statement. All applicable registration fees were previously paid on March 14, 2023. 10105135 17749233 1754852 1487771 357934 495055 409648 255112 909666 0 0 101297 13537235 20088468 641906 532508 384092 1480980 14563233 22101956 326641 136310 130678 558426 16942500 19188724 920780 0 123640 259256 731730 440196 3092000 0 22267969 20582912 3087651 0 1021811 1052960 26377431 21635872 0.001 0.001 42000000 42000000 28899402 28899402 24102866 24102866 28899 24103 40991377 38295775 -51875211 -37731476 -959263 -122318 -11814198 466084 14563233 22101956 77044 503906 75328 344300 1478108 -0 -1476392 159606 1538615 1556988 5600188 6173049 980039 0 8118842 7730037 -9595234 -7570431 -6412501 -6666630 -1864000 -14143735 -14237061 -0 -350256 -14143735 -13886805 -836946 -257885 -14980681 -14144690 -0.57 -0.57 -0.59 -0.59 24878196 24878196 23383758 23383758 22941157 22941 32044335 -23844671 135567 8358172 50765 772524 773 3067254 3068027 366892 367 2963291 2963658 22293 22 87366 87388 133529 133529 -257885 -257885 -13886805 -13886805 24102866 24103 38295775 -37731476 -122318 466084 4796536 4796 7651602 7656398 -4956000 -4956000 -836946 -836946 -14143735 -14143735 28899402 28899 40991377 -51875211 -959263 -11814198 -14143735 -13886805 444177 229810 1871593 6666630 2240339 0 2304539 0 1478108 0 980039 0 291534 440196 1864000 -0 0 220917 1745189 637149 17415 -519346 909666 -0 190331 -117384 -427748 310490 -1022077 250092 -166765 0 -8451781 -6504041 376170 481718 135168 83691 27879 391073 -539217 -956482 8394056 3118792 737658 50765 0 2963658 4700000 0 10274281 12400000 2082117 -6368315 -6908881 -13828838 -735217 -287300 17749233 31865371 10105135 17749233 0 0 0 0 4956000 0 2240339 2764775 <p id="xdx_806_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zFwaGsEu5dZ5" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 1 – <span id="xdx_82F_zMvFC0y5Uw5i">ORGANIZATION, PRINCIPAL ACTIVITIES AND MANAGEMENT’S PLANS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Nemaura Medical Inc. (“Nemaura” or the “Company”), through its operating subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (“CGM”), named sugarBEAT®. The sugarBEAT® device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. The sugarBEAT® device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using unique sensors and interpreted using a unique algorithm.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Nemaura is a Nevada holding company organized in 2013. Nemaura owns one hundred percent (100%) of Dermal Diagnostic (Holdings) Limited, an England and Wales corporation (“DDHL”) formed on December 11, 2013, which in turn owns one hundred percent (100%) of Dermal Diagnostics Limited, an England and Wales corporation formed on January 20, 2009 (“DDL”), and one hundred percent (100%) of Trial Clinic Limited, an England and Wales corporation formed on January 12, 2011 (“TCL”).</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">DDL is a diagnostic medical device company headquartered in Loughborough, Leicestershire, England, and is engaged in the discovery, development and commercialization of diagnostic medical devices. The Company’s initial focus has been on the development of the sugarBEAT® device, which consists of a disposable patch containing a sensor, and a non-disposable miniature transmitter device with a re-chargeable power source, which is designed to enable trending or tracking of blood glucose levels. All of the Company’s operations and assets are located in England.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company was incorporated in 2013 and has reported recurring losses from operations to date. These operations have resulted in the successful completion of clinical programs to support a CE mark (European Union approval of the product) approval, as well as a De Novo 510(k) medical device application to the U.S. Food and Drug Administration (“FDA”) submission. The Company expects to continue to incur losses from operations until revenues are generated through licensing fees or product sales. However, given the completion of the requisite clinical programs, these losses are expected to decrease over time. Management has entered into licensing, supply, or collaboration agreements with unrelated third parties relating to the United Kingdom (“UK”), Europe, Qatar, and all countries in the Gulf Cooperation Council.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0"><b>Going Concern</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the year ended March 31, 2023, the Company recorded a net loss of $<span id="xdx_902_eus-gaap--NetIncomeLoss_iN_di_c20220401__20230331_zXzgbE4iiK19" title="Net loss">14,143,735</span> and used cash in operations of $<span id="xdx_905_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20220401__20230331_zUU0Isc7nr4a" title="Cash in operations">8,451,781</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0">In evaluating the going concern position of the company, management has considered potential funding providers and believes that financing to fund future operations could be provided by equity and/or debt financing. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> -14143735 -8451781 <p id="xdx_803_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_z5UjB4b2VMi4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>NOTE 2 – <span id="xdx_824_zmBFV04mDg67">BASIS OF PRESENTATION</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The accompanying consolidated financial statements include the accounts of the Company and the Company’s subsidiaries, DDL, TCL, and DDHL. The consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and all intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The functional currency for the majority of the Company’s operations is the Great Britain Pound Sterling (“GBP”), and the reporting currency is the U.S. Dollar (“$”, “USD”).</p> <p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_z3lvljWnLvjf" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 3 – <span id="xdx_82C_zgeq5tcYFyP9">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zbW3CxOPUqYk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_864_zLE2O2MNsyd8">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant estimates include the assumptions used in the accrual for potential liabilities, the net realizable value of inventory, the valuation of debt and equity instruments, the fair value of derivative liabilities, valuation of stock options issued for services, and deferred tax valuation allowances. Actual results may differ from those estimates.<b> </b></p> <p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zHMc9X4sw1ci" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_863_z0cFhJf3SGW">Revenue recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company may enter into product development and other agreements with collaborative partners. The terms of the agreements may include non-refundable signing and licensing fees, milestone payments and royalties on any product sales derived from collaborations.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Royalty revenue will be recognized upon the sale of the related products provided the Company has no remaining performance obligations under the agreement.</p> <p id="xdx_84D_ecustom--DeferredRevenuePolicyTextBlock_zWgUrwiTZ3bf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_860_zKqJgyY4RSp4">Deferred revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company has entered into license agreements and recognizes up front license payments as revenue upon delivery of the license only if the license has stand-alone value to the customer. However, where further performance criteria must be met, revenue is deferred and recognized on a basis that is considered to be appropriate to the conditions associated with the license and over the period the Company is expected to complete these performance obligations.</p> <p id="xdx_84B_eus-gaap--ResearchAndDevelopmentExpensePolicy_zFxSc2Ze84K2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86E_zl5mWz9XVya5">Research and development expenses</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company charges research and development expenses to operations as incurred. Research and development expenses primarily consist of salaries and related expenses for personnel and outside contractor and consulting services. Other research and development expenses include the costs of materials and supplies used in research and development, prototype manufacturing, clinical studies, related information technology and an allocation of facilities costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z4zS2Gk7OOTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_866_zSOJYQLrBpeb">Cash and cash equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cash and cash equivalents consists primarily of cash deposits maintained in the UK.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain cash balances in U.S. Dollar (“USD”), Great Britain Pound Sterling (“GBP”), and the Euro. The following table, reported in USD, disaggregates our cash balances by currency denomination:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_z7Rm6idaOrw6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt"><span id="xdx_8B1_zcgPUexbe5a3" style="display: none">Schedule of disaggregates cash balances by currency denomination</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>March 31, <br/> 2023</b></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>March 31, <br/> 2022</b></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt">Cash denominated in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt">USD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--USD_zn5oIw6Fmrnc" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Cash and cash equivalents">5,606,972</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--USD_zkYx0hkcCNs1" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Cash and cash equivalents">14,769,720</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt">GBP</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--GBP_zoUBBxgyYlv3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">4,446,720</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--GBP_z9nqHBy0poIk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">2,911,117</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Euro</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--EUR_zNyigJvnhI4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">51,443</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--EUR_z0JqPXygKbS7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">68,396</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331_zifLh6DStqw3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash and cash equivalents">10,105,135</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331_z0wVf44q8sul" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash and cash equivalents">17,749,233</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zeBSyWj5K06e" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zmwfAVjf3z51" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86D_ziJqPJpgIotg">Inventory</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (“FIFO”) basis. The Company records adjustments to its inventory based on an estimated forecast of the inventory demand, taking into consideration, among others, inventory turnover, inventory quantities on hand, unfilled customer order quantities, and forecasted demand. If the estimated net realizable value is determined to be less than the recorded cost of the inventory, the difference is recognized as a loss in the period in which it occurs. Once inventory has been written down, it creates a new cost basis for inventory that may not be subsequently written up.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zslCDYacfMdf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_860_zt1nEdFg33Kg">Property and equipment</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets, generally four to five years. Depreciation is charged to operating expenses.</p> <p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zT2mBL3kga91" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86F_zph1CcHHXmxi">Intangible assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Intangible assets consist of licenses and patents associated primarily with the sugarBEAT® device and are amortized on a straight-line basis, generally over the shorter of their estimated useful lives or legal lives. Costs capitalized relate to invoices received from third parties and not any internal costs. The Company evaluates its intangible assets (all have finite lives) and other long-lived assets for impairment whenever events or circumstances indicate that they may not be recoverable, or at least annually. Recoverability of finite life intangibles and other long-lived assets is measured by comparing the carrying amount of an asset group to the future undiscounted net cash flows expected to be generated by that asset group. The Company groups assets for purposes of such review at the lowest level for which identifiable cash flows of the asset group are largely independent of the cash flows of the other groups of assets and liabilities. The amount of impairment to be recognized for finite life intangibles and other long-lived assets is calculated as the difference between the carrying value and the fair value of the asset group, generally measured by discounting estimated future cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_84E_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zFvcZTQtiXda" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_866_zI1D7JhPicdb">Software development costs</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The Company capitalizes costs incurred to implement software for its internal use, including hosted applications costs to support the Company’s planned services. During the year ended March 31, 2023, the Company determined that software development costs were impaired and recorded an impairment of $<span id="xdx_90E_eus-gaap--CapitalizedComputerSoftwareGross_iI_c20230331_zCeNY6Rn2Kge" title="Software develpoment costs">655,641</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z57zhcANAy2g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_866_z7tAqlZ9z4i8">Income taxes</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss carry forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided to reduce the carrying amount of deferred income tax assets if it is considered more likely than not that some portion, or all, of the deferred income tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company has elected to classify interest and penalties related to unrecognized tax benefits as part of income tax expense in the consolidated statements of comprehensive loss. The Company does <span id="xdx_902_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_do_c20220401__20230331_zB3KR5ku1mzl" title="Unrecognized tax benefits"><span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_do_c20210401__20220331_znI3RPAvEkV7" title="Unrecognized tax benefits">no</span></span>t have any accrued interest or penalties associated with any unrecognized tax benefits, nor was any interest expense related to unrecognized tax benefits recognized for the years ended March 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zrwbY4gFJPFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_863_zz9jSX0q7t0j">Earnings (loss) per share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Basic loss per share is computed by dividing the loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted loss per common share reflects the potential dilution that could occur if convertible debentures, options and warrants were to be exercised or converted or otherwise resulted in the issuance of common stock that then shared in the earnings of the entity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9pt; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">Since the effects of outstanding options and warrants are anti-dilutive for the years ended March 31, 2023 and 2022, shares of common stock underlying these instruments have been excluded from the computation of loss per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The following sets forth the number of shares of common stock underlying outstanding options and warrants as of March 31, 2023 and 2022:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zMiVUHMFFfgg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left; text-indent: 13.5pt"><span id="xdx_8B5_zcbsxRvQILq7" style="display: none">Schedule of common stock underlying outstanding options</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font-size: 8pt"> </td> <td colspan="2" style="font-size: 8pt; text-align: right"> </td><td style="font-size: 8pt"> </td><td style="font-size: 8pt"> </td> <td colspan="2" style="font-size: 8pt; text-align: right"> </td><td style="font-size: 8pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; padding-left: 14.2pt">Warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__us-gaap--AwardTypeAxis__custom--WarrantsMember_zWkg2fSTa7n9" style="width: 14%; text-align: right" title="Warrant outstanding">6,369,304</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--AwardTypeAxis__custom--WarrantsMember_ztRjvHLLpQ96" style="width: 14%; text-align: right" title="Warrant outstanding">1,573,098</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left; text-indent: 13.5pt">Stock options </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zFsjH8Kt5tef" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zSfwo2H5NN9l" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 12pt; padding-left: 14.2pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 12pt"></td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331_zBq9cziqtYq8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrant outstanding">6,409,304</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331_z9aq3eAdAQw6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrant outstanding">1,613,098</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zbqWI2WVMhUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zBZxfFEZG4ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zRdfjNRRAjH">Foreign currency translation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company is the GBP, while the reporting currency is the USD. Assets and liabilities are translated into USD using the exchange rate on the balance sheet date, and the amounts of revenue and expense are translated at the average exchange rate prevailing during the period. Stockholders' equity is translated at historical exchange rates. The gains and losses resulting from translation of financial statement amounts into USD are recorded as a separate component of accumulated other comprehensive loss within stockholders’ deficit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We used the exchange rates in the following table to translate amounts denominated in non-USD currencies as of and for the periods noted:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 24pt"></p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfTableToTranslateAmountsDenominatedInNonUsdCurrenciesTableTextBlock_z4y8eHhirrAl" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 2)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt"><span id="xdx_8BB_zAv327aP7SI9" style="display: none">Schedule of exchange rates translate amounts</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><p style="font: 9pt/107% Arial, Helvetica, Sans-Serif; margin: 0"></p></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">As of <br/> March 31,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">2023</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">2022</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Exchange rates at March 31:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt">GBP:USD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230331__srt--CurrencyAxis__currency--GBP_zwPn89mZ0J6c" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency exchange rates">1.236</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220331__srt--CurrencyAxis__currency--GBP_zO7bSk0IMWeh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency exchange rates">1.316</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt">EURO:USD</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230331__srt--CurrencyAxis__currency--EUR_zEJHE5vIglJc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates">1.138</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220331__srt--CurrencyAxis__currency--EUR_zj0tr6sHAp02" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates">1.184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">For the Years Ended <br/> March 31,</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Average exchange rate during the year ended March 31:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GBP:USD</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ForeignCurrencyAverageExchangeRates1_iI_c20230331__srt--CurrencyAxis__currency--GBP_zG3XcUIAlu58" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency average exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.215</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ForeignCurrencyAverageExchangeRates1_iI_d0_c20220331__srt--CurrencyAxis__currency--GBP_zRH3Y8J7XLhf" style="width: 14%; text-align: right" title="Foreign currency average exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.342</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zDEKlApRkDM3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_z5ReRIra8Nz7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_868_z4MR2BPD7NO4">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, "Derivatives and Hedging" (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company’s use of derivative financial instruments is generally limited to managing foreign exchange rate risks. In addition, warrants issued by the Company that do not meet the criteria for equity treatment are recorded as liabilities. We do not use financial instruments or derivatives for any trading purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--FairValueDisclosuresTextBlock_zHm1NfFWAE9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_zsxSB42R4pKh">Fair value of financial instruments</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">In accordance with ASC 820, “Fair Value Measurements and Disclosures,” the Company determines the fair value of financial instruments with the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Level 1</i>: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Level 2</i>: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><i>Level 3</i>: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, based on the lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels, the Company performs an analysis of the assets and liabilities at each reporting period end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth by level, within the fair value hierarchy, the Company’s assets and liabilities at fair value as of March 31, 2023 and 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zL5Tkpr80El8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 3)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8BD_zLm6LxfEoMQ9" style="display: none">Schedule of assets and liabilities at fair value</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="text-decoration: underline">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zG2qug4JTEzj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdo7EjceSkY5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUo2bj0LSyl4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zm0EhzPJT99a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: justify">Foreign exchange contract derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z8aY3fUxAzZe" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7nKDfbTNzHd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEGOtxfbIgO2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zVq1qmSb2ead" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Warrant derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--WarrantDerivativeLiabilityFairValue_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWrAm1RAtval" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--WarrantDerivativeLiabilityFairValue_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXAIzc66fL05" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--WarrantDerivativeLiabilityFairValue_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwGs8GMwuEJf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--WarrantDerivativeLiabilityFairValue_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zJMFmv9PwYBg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI6vN3ejuYW4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zR45Qsc4M31" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zV9bVIG3OIBg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zGpQhmMihtB2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">3,823,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="text-decoration: underline">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4Cvob32ZUQb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrIlhQj7S4Ne" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHyMpUDgrr93" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zVnvsbBvq4I7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left; padding-bottom: 1pt">Foreign exchange contract derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z69il7428dYl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBwNZXDrbg81" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlq7lA4gimbf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_z0VVRruRhrS5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zog6YMElTbAk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuhBSjJX62E" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTMVKvTBE3Id" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zvStqQrWORKb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zEs3aO6iOgdi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2022, there was no warrant derivative liability. The following table provides a roll-forward of the warrant derivative liability measured at fair value on a recurring basis using unobservable level 3 inputs for the year ended March 31, 2023 as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_z7klsbBbP5dh" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 4)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_8BB_zjXNbBcqLwub" style="display: none">Schedule of warrant derivative liability measured at fair value on a recurring basis</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: justify">Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance as of beginning of period – March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--WarrantDerivativeLiability_iS_d0_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSudsm5XBxDd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability, beginning balance">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: justify">Fair value of warrant liability recognized upon issuance of warrants in January 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--FairValueOfWarrantDerivativeLiabilityRecognizedUponIssuanceOfWarrants_d0_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zyHNARMYjtHl" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Fair value of warrant derivative liability recognized upon issuance of warrants">4,956,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Change in fair value of warrant derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--GainOnChangeInFairValueOfWarrantDerivativeLiability_iN_di_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCZkG329yuTh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on change in fair value of warrant derivative liability">(1,864,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Balance as of end of period – March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--WarrantDerivativeLiability_iE_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqta3VGgn09i" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability, ending balance">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zYX2EWi6ELWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes the carrying amount of its financial instruments (consisting of cash, accounts receivable, and accounts payable and accrued liabilities) approximates fair value due to the short-term nature of such instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_84A_eus-gaap--PostemploymentBenefitPlansPolicy_zFEhrcPOeRpk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_863_zhFQfjiWNDQg">Retirement benefit plan</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company operates a retirement plan which covers most of our regular employees in the UK and allows them to make contributions. The Company also provides a matching contribution on a portion of the employee contributions. Total expenses incurred under this plan for the fiscal years ended March 31, 2023 and 2022, were $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_pp0p0_c20220401__20230331_z1gtQKv0Fa91" title="Retirement benefit plan expenses">37,645</span> and $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_pp0p0_c20210401__20220331_zcnqvcw54o4h" title="Retirement benefit plan expenses">24,300</span>, respectively. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_840_ecustom--StockbasedCompensationPolicyTextBlock_zBDJZLT02sX" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-weight: normal"><i><span id="xdx_861_z53o7nMqZ4cc">Stock-based compensation</span></i></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation </i>whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>The fair value of the Company’s stock options is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_848_ecustom--DirectCostsIncurredForEquityOfferingsPolicyTextBlock_zWROmqtcRyB3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86A_z8yjbFyudWZ">Direct costs incurred for equity offerings</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company includes all direct costs incurred in connection with successful equity offerings as a component of additional paid-in capital. Direct costs incurred for equity offerings that are unsuccessful are expensed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zXFZ4QEzn7X1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_869_zpnvBYVheGKj">Reclassifications</span></i></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Certain prior year balances have been reclassified to conform with the current year presentation. In presenting the Company’s consolidated balance sheet at March 31, 2022, the Company presented $<span id="xdx_90B_eus-gaap--ValueAddedTaxReceivable_iI_c20220331_zWZYIUf6iHrd" title="VAT receivable">255,112</span> VAT receivable as part of prepaid expenses and other receivables of $<span id="xdx_909_eus-gaap--PrepaidExpenseAndOtherAssets_iI_c20220331_zjLgSDpXNNfi" title="Prepaid expenses and other receivables">750,167</span>. In presenting the Company’s consolidated balance sheet at March 31, 2023, the Company has reclassified the balance of $<span id="xdx_908_eus-gaap--ValueAddedTaxReceivable_iI_c20230331_zxn5lED0jOb6" title="VAT receivable">255,112</span> as a separate line item VAT receivable, and the balance of $<span id="xdx_90E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20220331_zW1uqmMme1b1" title="Prepaid expenses balance">495,055</span> is presented as prepaid expenses in the accompanying March 31, 2022 financial statements.<i> </i></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zTflOCqwO186" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_865_zCjP0Dyxxzmb">Recent accounting pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its consolidated financial statements and assures that there are proper controls in place to ascertain that the Company's consolidated financial statements properly reflect the change.</p> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zbW3CxOPUqYk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_864_zLE2O2MNsyd8">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant estimates include the assumptions used in the accrual for potential liabilities, the net realizable value of inventory, the valuation of debt and equity instruments, the fair value of derivative liabilities, valuation of stock options issued for services, and deferred tax valuation allowances. Actual results may differ from those estimates.<b> </b></p> <p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zHMc9X4sw1ci" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_863_z0cFhJf3SGW">Revenue recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company may enter into product development and other agreements with collaborative partners. The terms of the agreements may include non-refundable signing and licensing fees, milestone payments and royalties on any product sales derived from collaborations.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Royalty revenue will be recognized upon the sale of the related products provided the Company has no remaining performance obligations under the agreement.</p> <p id="xdx_84D_ecustom--DeferredRevenuePolicyTextBlock_zWgUrwiTZ3bf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_860_zKqJgyY4RSp4">Deferred revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company has entered into license agreements and recognizes up front license payments as revenue upon delivery of the license only if the license has stand-alone value to the customer. However, where further performance criteria must be met, revenue is deferred and recognized on a basis that is considered to be appropriate to the conditions associated with the license and over the period the Company is expected to complete these performance obligations.</p> <p id="xdx_84B_eus-gaap--ResearchAndDevelopmentExpensePolicy_zFxSc2Ze84K2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86E_zl5mWz9XVya5">Research and development expenses</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company charges research and development expenses to operations as incurred. Research and development expenses primarily consist of salaries and related expenses for personnel and outside contractor and consulting services. Other research and development expenses include the costs of materials and supplies used in research and development, prototype manufacturing, clinical studies, related information technology and an allocation of facilities costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z4zS2Gk7OOTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_866_zSOJYQLrBpeb">Cash and cash equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cash and cash equivalents consists primarily of cash deposits maintained in the UK.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain cash balances in U.S. Dollar (“USD”), Great Britain Pound Sterling (“GBP”), and the Euro. The following table, reported in USD, disaggregates our cash balances by currency denomination:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_z7Rm6idaOrw6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt"><span id="xdx_8B1_zcgPUexbe5a3" style="display: none">Schedule of disaggregates cash balances by currency denomination</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>March 31, <br/> 2023</b></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>March 31, <br/> 2022</b></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt">Cash denominated in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt">USD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--USD_zn5oIw6Fmrnc" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Cash and cash equivalents">5,606,972</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--USD_zkYx0hkcCNs1" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Cash and cash equivalents">14,769,720</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt">GBP</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--GBP_zoUBBxgyYlv3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">4,446,720</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--GBP_z9nqHBy0poIk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">2,911,117</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Euro</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--EUR_zNyigJvnhI4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">51,443</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--EUR_z0JqPXygKbS7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">68,396</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331_zifLh6DStqw3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash and cash equivalents">10,105,135</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331_z0wVf44q8sul" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash and cash equivalents">17,749,233</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zeBSyWj5K06e" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfIntercompanyForeignCurrencyBalancesTextBlock_z7Rm6idaOrw6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt"><span id="xdx_8B1_zcgPUexbe5a3" style="display: none">Schedule of disaggregates cash balances by currency denomination</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>March 31, <br/> 2023</b></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>March 31, <br/> 2022</b></span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt">Cash denominated in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt">USD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--USD_zn5oIw6Fmrnc" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Cash and cash equivalents">5,606,972</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--USD_zkYx0hkcCNs1" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Cash and cash equivalents">14,769,720</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt">GBP</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--GBP_zoUBBxgyYlv3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">4,446,720</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--GBP_z9nqHBy0poIk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">2,911,117</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Euro</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331__srt--CurrencyAxis__currency--EUR_zNyigJvnhI4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">51,443</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331__srt--CurrencyAxis__currency--EUR_z0JqPXygKbS7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash and cash equivalents">68,396</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230331_zifLh6DStqw3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash and cash equivalents">10,105,135</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20220331_z0wVf44q8sul" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash and cash equivalents">17,749,233</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5606972 14769720 4446720 2911117 51443 68396 10105135 17749233 <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zmwfAVjf3z51" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86D_ziJqPJpgIotg">Inventory</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (“FIFO”) basis. The Company records adjustments to its inventory based on an estimated forecast of the inventory demand, taking into consideration, among others, inventory turnover, inventory quantities on hand, unfilled customer order quantities, and forecasted demand. If the estimated net realizable value is determined to be less than the recorded cost of the inventory, the difference is recognized as a loss in the period in which it occurs. Once inventory has been written down, it creates a new cost basis for inventory that may not be subsequently written up.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zslCDYacfMdf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_860_zt1nEdFg33Kg">Property and equipment</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets, generally four to five years. Depreciation is charged to operating expenses.</p> <p id="xdx_84C_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zT2mBL3kga91" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86F_zph1CcHHXmxi">Intangible assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Intangible assets consist of licenses and patents associated primarily with the sugarBEAT® device and are amortized on a straight-line basis, generally over the shorter of their estimated useful lives or legal lives. Costs capitalized relate to invoices received from third parties and not any internal costs. The Company evaluates its intangible assets (all have finite lives) and other long-lived assets for impairment whenever events or circumstances indicate that they may not be recoverable, or at least annually. Recoverability of finite life intangibles and other long-lived assets is measured by comparing the carrying amount of an asset group to the future undiscounted net cash flows expected to be generated by that asset group. The Company groups assets for purposes of such review at the lowest level for which identifiable cash flows of the asset group are largely independent of the cash flows of the other groups of assets and liabilities. The amount of impairment to be recognized for finite life intangibles and other long-lived assets is calculated as the difference between the carrying value and the fair value of the asset group, generally measured by discounting estimated future cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_84E_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zFvcZTQtiXda" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_866_zI1D7JhPicdb">Software development costs</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The Company capitalizes costs incurred to implement software for its internal use, including hosted applications costs to support the Company’s planned services. During the year ended March 31, 2023, the Company determined that software development costs were impaired and recorded an impairment of $<span id="xdx_90E_eus-gaap--CapitalizedComputerSoftwareGross_iI_c20230331_zCeNY6Rn2Kge" title="Software develpoment costs">655,641</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> 655641 <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z57zhcANAy2g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_866_z7tAqlZ9z4i8">Income taxes</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss carry forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided to reduce the carrying amount of deferred income tax assets if it is considered more likely than not that some portion, or all, of the deferred income tax assets will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company has elected to classify interest and penalties related to unrecognized tax benefits as part of income tax expense in the consolidated statements of comprehensive loss. The Company does <span id="xdx_902_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_do_c20220401__20230331_zB3KR5ku1mzl" title="Unrecognized tax benefits"><span id="xdx_90B_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_do_c20210401__20220331_znI3RPAvEkV7" title="Unrecognized tax benefits">no</span></span>t have any accrued interest or penalties associated with any unrecognized tax benefits, nor was any interest expense related to unrecognized tax benefits recognized for the years ended March 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> 0 0 <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zrwbY4gFJPFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_863_zz9jSX0q7t0j">Earnings (loss) per share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Basic loss per share is computed by dividing the loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted loss per common share reflects the potential dilution that could occur if convertible debentures, options and warrants were to be exercised or converted or otherwise resulted in the issuance of common stock that then shared in the earnings of the entity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9pt; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">Since the effects of outstanding options and warrants are anti-dilutive for the years ended March 31, 2023 and 2022, shares of common stock underlying these instruments have been excluded from the computation of loss per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">The following sets forth the number of shares of common stock underlying outstanding options and warrants as of March 31, 2023 and 2022:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zMiVUHMFFfgg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left; text-indent: 13.5pt"><span id="xdx_8B5_zcbsxRvQILq7" style="display: none">Schedule of common stock underlying outstanding options</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font-size: 8pt"> </td> <td colspan="2" style="font-size: 8pt; text-align: right"> </td><td style="font-size: 8pt"> </td><td style="font-size: 8pt"> </td> <td colspan="2" style="font-size: 8pt; text-align: right"> </td><td style="font-size: 8pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; padding-left: 14.2pt">Warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__us-gaap--AwardTypeAxis__custom--WarrantsMember_zWkg2fSTa7n9" style="width: 14%; text-align: right" title="Warrant outstanding">6,369,304</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--AwardTypeAxis__custom--WarrantsMember_ztRjvHLLpQ96" style="width: 14%; text-align: right" title="Warrant outstanding">1,573,098</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left; text-indent: 13.5pt">Stock options </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zFsjH8Kt5tef" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zSfwo2H5NN9l" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 12pt; padding-left: 14.2pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 12pt"></td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331_zBq9cziqtYq8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrant outstanding">6,409,304</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331_z9aq3eAdAQw6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrant outstanding">1,613,098</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zbqWI2WVMhUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zMiVUHMFFfgg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: left; text-indent: 13.5pt"><span id="xdx_8B5_zcbsxRvQILq7" style="display: none">Schedule of common stock underlying outstanding options</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font-size: 8pt"> </td> <td colspan="2" style="font-size: 8pt; text-align: right"> </td><td style="font-size: 8pt"> </td><td style="font-size: 8pt"> </td> <td colspan="2" style="font-size: 8pt; text-align: right"> </td><td style="font-size: 8pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; padding-left: 14.2pt">Warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__us-gaap--AwardTypeAxis__custom--WarrantsMember_zWkg2fSTa7n9" style="width: 14%; text-align: right" title="Warrant outstanding">6,369,304</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--AwardTypeAxis__custom--WarrantsMember_ztRjvHLLpQ96" style="width: 14%; text-align: right" title="Warrant outstanding">1,573,098</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left; text-indent: 13.5pt">Stock options </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zFsjH8Kt5tef" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--AwardTypeAxis__custom--StockOptionsMember_zSfwo2H5NN9l" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant outstanding">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 12pt; padding-left: 14.2pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; font-size: 12pt"></td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331_zBq9cziqtYq8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrant outstanding">6,409,304</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331_z9aq3eAdAQw6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrant outstanding">1,613,098</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> </table> 6369304 1573098 40000 40000 6409304 1613098 <p id="xdx_84A_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zBZxfFEZG4ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zRdfjNRRAjH">Foreign currency translation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company is the GBP, while the reporting currency is the USD. Assets and liabilities are translated into USD using the exchange rate on the balance sheet date, and the amounts of revenue and expense are translated at the average exchange rate prevailing during the period. Stockholders' equity is translated at historical exchange rates. The gains and losses resulting from translation of financial statement amounts into USD are recorded as a separate component of accumulated other comprehensive loss within stockholders’ deficit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We used the exchange rates in the following table to translate amounts denominated in non-USD currencies as of and for the periods noted:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify; text-indent: 24pt"></p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfTableToTranslateAmountsDenominatedInNonUsdCurrenciesTableTextBlock_z4y8eHhirrAl" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 2)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt"><span id="xdx_8BB_zAv327aP7SI9" style="display: none">Schedule of exchange rates translate amounts</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><p style="font: 9pt/107% Arial, Helvetica, Sans-Serif; margin: 0"></p></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">As of <br/> March 31,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">2023</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">2022</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Exchange rates at March 31:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt">GBP:USD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230331__srt--CurrencyAxis__currency--GBP_zwPn89mZ0J6c" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency exchange rates">1.236</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220331__srt--CurrencyAxis__currency--GBP_zO7bSk0IMWeh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency exchange rates">1.316</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt">EURO:USD</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230331__srt--CurrencyAxis__currency--EUR_zEJHE5vIglJc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates">1.138</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220331__srt--CurrencyAxis__currency--EUR_zj0tr6sHAp02" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates">1.184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">For the Years Ended <br/> March 31,</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Average exchange rate during the year ended March 31:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GBP:USD</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ForeignCurrencyAverageExchangeRates1_iI_c20230331__srt--CurrencyAxis__currency--GBP_zG3XcUIAlu58" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency average exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.215</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ForeignCurrencyAverageExchangeRates1_iI_d0_c20220331__srt--CurrencyAxis__currency--GBP_zRH3Y8J7XLhf" style="width: 14%; text-align: right" title="Foreign currency average exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.342</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zDEKlApRkDM3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfTableToTranslateAmountsDenominatedInNonUsdCurrenciesTableTextBlock_z4y8eHhirrAl" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 2)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt"><span id="xdx_8BB_zAv327aP7SI9" style="display: none">Schedule of exchange rates translate amounts</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><p style="font: 9pt/107% Arial, Helvetica, Sans-Serif; margin: 0"></p></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">As of <br/> March 31,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">2023</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">2022</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Exchange rates at March 31:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt">GBP:USD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230331__srt--CurrencyAxis__currency--GBP_zwPn89mZ0J6c" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency exchange rates">1.236</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220331__srt--CurrencyAxis__currency--GBP_zO7bSk0IMWeh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency exchange rates">1.316</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -10pt; padding-left: 10pt">EURO:USD</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20230331__srt--CurrencyAxis__currency--EUR_zEJHE5vIglJc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates">1.138</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220331__srt--CurrencyAxis__currency--EUR_zj0tr6sHAp02" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency exchange rates">1.184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">For the Years Ended <br/> March 31,</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif">Average exchange rate during the year ended March 31:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GBP:USD</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ForeignCurrencyAverageExchangeRates1_iI_c20230331__srt--CurrencyAxis__currency--GBP_zG3XcUIAlu58" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Foreign currency average exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.215</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ForeignCurrencyAverageExchangeRates1_iI_d0_c20220331__srt--CurrencyAxis__currency--GBP_zRH3Y8J7XLhf" style="width: 14%; text-align: right" title="Foreign currency average exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.342</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1.236 1.316 1.138 1.184 1.215 1.342 <p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_z5ReRIra8Nz7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_868_z4MR2BPD7NO4">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, "Derivatives and Hedging" (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company’s use of derivative financial instruments is generally limited to managing foreign exchange rate risks. In addition, warrants issued by the Company that do not meet the criteria for equity treatment are recorded as liabilities. We do not use financial instruments or derivatives for any trading purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--FairValueDisclosuresTextBlock_zHm1NfFWAE9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_zsxSB42R4pKh">Fair value of financial instruments</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">In accordance with ASC 820, “Fair Value Measurements and Disclosures,” the Company determines the fair value of financial instruments with the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Level 1</i>: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Level 2</i>: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><i>Level 3</i>: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company determines the level in the fair value hierarchy within which each fair value measurement falls in its entirety, based on the lowest level input that is significant to the fair value measurement in its entirety. In determining the appropriate levels, the Company performs an analysis of the assets and liabilities at each reporting period end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth by level, within the fair value hierarchy, the Company’s assets and liabilities at fair value as of March 31, 2023 and 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zL5Tkpr80El8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 3)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8BD_zLm6LxfEoMQ9" style="display: none">Schedule of assets and liabilities at fair value</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="text-decoration: underline">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zG2qug4JTEzj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdo7EjceSkY5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUo2bj0LSyl4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zm0EhzPJT99a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: justify">Foreign exchange contract derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z8aY3fUxAzZe" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7nKDfbTNzHd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEGOtxfbIgO2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zVq1qmSb2ead" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Warrant derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--WarrantDerivativeLiabilityFairValue_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWrAm1RAtval" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--WarrantDerivativeLiabilityFairValue_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXAIzc66fL05" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--WarrantDerivativeLiabilityFairValue_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwGs8GMwuEJf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--WarrantDerivativeLiabilityFairValue_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zJMFmv9PwYBg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI6vN3ejuYW4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zR45Qsc4M31" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zV9bVIG3OIBg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zGpQhmMihtB2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">3,823,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="text-decoration: underline">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4Cvob32ZUQb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrIlhQj7S4Ne" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHyMpUDgrr93" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zVnvsbBvq4I7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left; padding-bottom: 1pt">Foreign exchange contract derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z69il7428dYl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBwNZXDrbg81" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlq7lA4gimbf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_z0VVRruRhrS5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zog6YMElTbAk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuhBSjJX62E" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTMVKvTBE3Id" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zvStqQrWORKb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zEs3aO6iOgdi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2022, there was no warrant derivative liability. The following table provides a roll-forward of the warrant derivative liability measured at fair value on a recurring basis using unobservable level 3 inputs for the year ended March 31, 2023 as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_z7klsbBbP5dh" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 4)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_8BB_zjXNbBcqLwub" style="display: none">Schedule of warrant derivative liability measured at fair value on a recurring basis</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: justify">Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance as of beginning of period – March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--WarrantDerivativeLiability_iS_d0_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSudsm5XBxDd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability, beginning balance">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: justify">Fair value of warrant liability recognized upon issuance of warrants in January 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--FairValueOfWarrantDerivativeLiabilityRecognizedUponIssuanceOfWarrants_d0_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zyHNARMYjtHl" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Fair value of warrant derivative liability recognized upon issuance of warrants">4,956,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Change in fair value of warrant derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--GainOnChangeInFairValueOfWarrantDerivativeLiability_iN_di_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCZkG329yuTh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on change in fair value of warrant derivative liability">(1,864,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Balance as of end of period – March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--WarrantDerivativeLiability_iE_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqta3VGgn09i" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability, ending balance">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zYX2EWi6ELWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes the carrying amount of its financial instruments (consisting of cash, accounts receivable, and accounts payable and accrued liabilities) approximates fair value due to the short-term nature of such instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zL5Tkpr80El8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 3)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8BD_zLm6LxfEoMQ9" style="display: none">Schedule of assets and liabilities at fair value</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="text-decoration: underline">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zG2qug4JTEzj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdo7EjceSkY5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUo2bj0LSyl4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zm0EhzPJT99a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: justify">Foreign exchange contract derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z8aY3fUxAzZe" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7nKDfbTNzHd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zEGOtxfbIgO2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zVq1qmSb2ead" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Warrant derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--WarrantDerivativeLiabilityFairValue_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWrAm1RAtval" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--WarrantDerivativeLiabilityFairValue_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXAIzc66fL05" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--WarrantDerivativeLiabilityFairValue_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwGs8GMwuEJf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--WarrantDerivativeLiabilityFairValue_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zJMFmv9PwYBg" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI6vN3ejuYW4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zR45Qsc4M31" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zV9bVIG3OIBg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zGpQhmMihtB2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">3,823,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 1</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 2</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Level 3</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="text-decoration: underline">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4Cvob32ZUQb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrIlhQj7S4Ne" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHyMpUDgrr93" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zVnvsbBvq4I7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left; padding-bottom: 1pt">Foreign exchange contract derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z69il7428dYl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zBwNZXDrbg81" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlq7lA4gimbf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">—</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_z0VVRruRhrS5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Foreign exchange contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zog6YMElTbAk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuhBSjJX62E" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_d0_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTMVKvTBE3Id" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20220331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel12And3Member_zvStqQrWORKb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total liabilities">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 0 0 0 0 731730 0 731730 0 0 3092000 3092000 0 731730 3092000 3823730 0 0 0 0 0 440196 0 440196 0 440196 0 440196 <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_z7klsbBbP5dh" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS (Details 4)"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_8BB_zjXNbBcqLwub" style="display: none">Schedule of warrant derivative liability measured at fair value on a recurring basis</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: justify">Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Balance as of beginning of period – March 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--WarrantDerivativeLiability_iS_d0_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSudsm5XBxDd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability, beginning balance">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: justify">Fair value of warrant liability recognized upon issuance of warrants in January 2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--FairValueOfWarrantDerivativeLiabilityRecognizedUponIssuanceOfWarrants_d0_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zyHNARMYjtHl" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Fair value of warrant derivative liability recognized upon issuance of warrants">4,956,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Change in fair value of warrant derivative liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--GainOnChangeInFairValueOfWarrantDerivativeLiability_iN_di_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCZkG329yuTh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gain on change in fair value of warrant derivative liability">(1,864,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Balance as of end of period – March 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_ecustom--WarrantDerivativeLiability_iE_c20220401__20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqta3VGgn09i" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant derivative liability, ending balance">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 4956000 1864000 3092000 <p id="xdx_84A_eus-gaap--PostemploymentBenefitPlansPolicy_zFEhrcPOeRpk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_863_zhFQfjiWNDQg">Retirement benefit plan</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company operates a retirement plan which covers most of our regular employees in the UK and allows them to make contributions. The Company also provides a matching contribution on a portion of the employee contributions. Total expenses incurred under this plan for the fiscal years ended March 31, 2023 and 2022, were $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_pp0p0_c20220401__20230331_z1gtQKv0Fa91" title="Retirement benefit plan expenses">37,645</span> and $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_pp0p0_c20210401__20220331_zcnqvcw54o4h" title="Retirement benefit plan expenses">24,300</span>, respectively. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> 37645 24300 <p id="xdx_840_ecustom--StockbasedCompensationPolicyTextBlock_zBDJZLT02sX" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-weight: normal"><i><span id="xdx_861_z53o7nMqZ4cc">Stock-based compensation</span></i></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation </i>whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>The fair value of the Company’s stock options is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_848_ecustom--DirectCostsIncurredForEquityOfferingsPolicyTextBlock_zWROmqtcRyB3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_86A_z8yjbFyudWZ">Direct costs incurred for equity offerings</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company includes all direct costs incurred in connection with successful equity offerings as a component of additional paid-in capital. Direct costs incurred for equity offerings that are unsuccessful are expensed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zXFZ4QEzn7X1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><i><span id="xdx_869_zpnvBYVheGKj">Reclassifications</span></i></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Certain prior year balances have been reclassified to conform with the current year presentation. In presenting the Company’s consolidated balance sheet at March 31, 2022, the Company presented $<span id="xdx_90B_eus-gaap--ValueAddedTaxReceivable_iI_c20220331_zWZYIUf6iHrd" title="VAT receivable">255,112</span> VAT receivable as part of prepaid expenses and other receivables of $<span id="xdx_909_eus-gaap--PrepaidExpenseAndOtherAssets_iI_c20220331_zjLgSDpXNNfi" title="Prepaid expenses and other receivables">750,167</span>. In presenting the Company’s consolidated balance sheet at March 31, 2023, the Company has reclassified the balance of $<span id="xdx_908_eus-gaap--ValueAddedTaxReceivable_iI_c20230331_zxn5lED0jOb6" title="VAT receivable">255,112</span> as a separate line item VAT receivable, and the balance of $<span id="xdx_90E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20220331_zW1uqmMme1b1" title="Prepaid expenses balance">495,055</span> is presented as prepaid expenses in the accompanying March 31, 2022 financial statements.<i> </i></p> 255112 750167 255112 495055 <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zTflOCqwO186" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_865_zCjP0Dyxxzmb">Recent accounting pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its consolidated financial statements and assures that there are proper controls in place to ascertain that the Company's consolidated financial statements properly reflect the change.</p> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p id="xdx_809_eus-gaap--CommitmentsDisclosureTextBlock_zc10cShNrz" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 4 – <span id="xdx_82B_zOy148Tqkpif">LICENSING AGREEMENT</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In March 2014, the Company entered into an Exclusive Marketing Rights Agreement with an unrelated third party that granted to the third party the exclusive right to market and promote the sugarBEAT® device and related patches under its own brand in the United Kingdom and the Republic of Ireland, the Channel Islands and the Isle of Man. Upon signing the agreement, the Company received a wholly non-refundable cash payment of GBP <span id="xdx_908_eus-gaap--AdvanceRoyaltiesCurrent_iI_uGBP_c20230331_zK0aJpnawp74" title="Non refundable, upfront cash payment">1,000,000</span> (approximately $<span id="xdx_907_eus-gaap--AdvanceRoyalties_iI_pn3n3_dm_c20230331_z6H8J7yYIlW4" title="Non-refundable, upfront cash payment">1.23</span> million and $<span id="xdx_90D_eus-gaap--AdvanceRoyalties_iI_pn3n3_dm_c20220331_zfs3nTi1XPPg" title="Non-refundable, upfront cash payment">1.32</span> million as of March 31, 2023 and 2022, respectively).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">As the Company has continuing performance obligations under the agreement, the up-front fees received from this agreement have been deferred and will be recorded as income over the term of the commercial licensing agreement as the Company completes its performance obligations. At March 31, 2023, total deferred revenue for the licensing agreement was $<span id="xdx_90A_eus-gaap--DeferredRevenue_iI_c20230331_zpjVH8O08p6g">1,081,676</span>.</p> 1000000 1230000 1320000 1081676 <p id="xdx_803_eus-gaap--InventoryDisclosureTextBlock_ztrUj56A35xg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><b>NOTE 5 – <span id="xdx_82B_zlVVBg7tUNVf">INVENTORY</span></b></p> <p style="font: bold 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value and is comprised of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrWtgQGgWU8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORY (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zSyiBAEACMZa" style="display: none">Schedule of inventory</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_498_20230331_z1VeyF10wur1" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_492_20220331_zKUErkA0GTZj" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td></tr> <tr id="xdx_401_eus-gaap--InventoryRawMaterials_iI_maINzV2g_zCJ1vY5Ib8Ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Raw materials</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,586,777</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,481,946</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_maINzV2g_z1AEhnnNWdcc" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Finished products</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">168,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,825</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_mtINzV2g_zP7sdGpuJVz4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,754,852</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,487,771</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">At March 31, 2023, management determined that the net realizable value of the Company’s inventory had fallen below its historical carrying cost. Accordingly, for the year ended March 31, 2023, the Company recorded a write down of inventory of $<span id="xdx_904_eus-gaap--InventoryWriteDown_c20220401__20230331_zz4F29RBqtU3" title="Write down of inventory">1,478,108</span>, which is included in cost of goods sold. At March 31, 2023, the balance of inventory shown above reflects its new cost basis after the write down. For the year ended March 31, 2022, there was <span id="xdx_904_eus-gaap--InventoryWriteDown_do_c20210401__20220331_zI4DIckOnnJi" title="Write down of inventory">no</span> write down of inventory recorded.</p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrWtgQGgWU8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORY (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_zSyiBAEACMZa" style="display: none">Schedule of inventory</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_498_20230331_z1VeyF10wur1" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" id="xdx_492_20220331_zKUErkA0GTZj" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt">March 31, 2022</span></td></tr> <tr id="xdx_401_eus-gaap--InventoryRawMaterials_iI_maINzV2g_zCJ1vY5Ib8Ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Raw materials</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,586,777</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,481,946</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_maINzV2g_z1AEhnnNWdcc" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Finished products</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">168,075</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,825</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_mtINzV2g_zP7sdGpuJVz4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,754,852</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,487,771</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1586777 1481946 168075 5825 1754852 1487771 1478108 0 <p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zVljYpajuyPg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>NOTE 6 – <span id="xdx_820_zpPdPolIUhea">PROPERTY AND EQUIPMENT</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">As of March 31, 2023 and 2022, property and equipment is summarized as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmwErFGeniHh" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8BF_z9PUzTw2cHKl" style="display: none">Schedule of property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20230331_zOCDJvQqDzze" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20220331_zDk17lTt8hul" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"></td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"></td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"></td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and Equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--MachineryAndEquipmentGross_iI_pp0p0_maPPAEGzS5m_z0lYo5pLqFPl" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Plant and machinery</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">998,635</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">727,250</p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FurnitureAndFixturesGross_iI_pp0p0_maPPAEGzS5m_z65ojXD3OAG6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Furniture and fixtures</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">114,863</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">78,867</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iTI_pp0p0_mtPPAEGzS5m_maPPAENzpsa_z0qQOyhGlF74" style="vertical-align: bottom; background-color: White"> <td style="color: White">Property and equipment gross</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,113,498</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">806,117</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzpsa_zWHe4FaYUZG1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Less Accumulated Depreciation</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(471,592</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(273,609</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzpsa_zuI3cvLWEvub" style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Net Book Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">641,906</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">532,508</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">Depreciation expense relating to property and equipment for the years ended March 31, 2023 and 2022 was approximately $<span id="xdx_906_eus-gaap--Depreciation_pp0p0_c20220401__20230331_zyCpreW60J9f" title="Depreciation expense">156,000</span> and $<span id="xdx_90F_eus-gaap--Depreciation_pp0p0_c20210401__20220331_zLlOWZpWTMr2" title="Depreciation expense">138,000</span>, respectively.</p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--PropertyPlantAndEquipmentTextBlock_zmwErFGeniHh" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8BF_z9PUzTw2cHKl" style="display: none">Schedule of property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20230331_zOCDJvQqDzze" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20220331_zDk17lTt8hul" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">March 31,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"></td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"></td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center"></td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and Equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--MachineryAndEquipmentGross_iI_pp0p0_maPPAEGzS5m_z0lYo5pLqFPl" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Plant and machinery</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">998,635</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">727,250</p></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FurnitureAndFixturesGross_iI_pp0p0_maPPAEGzS5m_z65ojXD3OAG6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Furniture and fixtures</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">114,863</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">78,867</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iTI_pp0p0_mtPPAEGzS5m_maPPAENzpsa_z0qQOyhGlF74" style="vertical-align: bottom; background-color: White"> <td style="color: White">Property and equipment gross</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,113,498</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">806,117</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzpsa_zWHe4FaYUZG1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">Less Accumulated Depreciation</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(471,592</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(273,609</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzpsa_zuI3cvLWEvub" style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Net Book Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">641,906</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">532,508</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 998635 727250 114863 78867 1113498 806117 471592 273609 641906 532508 156000 138000 <p id="xdx_805_eus-gaap--IntangibleAssetsDisclosureTextBlock_z2zgzD7aoBTf" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 7 - <span id="xdx_82A_z5LhJpSfTsxk">INTANGIBLE ASSETS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif">The following table summarizes our intangible assets and capitalized software development costs at March 31, 2023:</p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zturhI381Ed4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><span id="xdx_8B2_zbeBlMaPblI3" style="display: none">Schedule of Intangible Assets</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 8pt"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">March 31,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2023<br/></b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2022<br/></b></span></p></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 12pt; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-left: 7.1pt">Patents and licenses</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> $</td><td id="xdx_98B_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zK8eRLjyseAg" style="width: 14%; text-align: right" title="Patents and licenses">1,175,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> $</td><td id="xdx_986_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zczaMqQK1Hcl" style="width: 14%; text-align: right" title="Patents and licenses">1,084,081</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Less accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z5aXSs8LAFUh" style="text-align: right" title="Less accumulated amortization">(467,091</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zUMWWhWWKbp7" style="text-align: right" title="Less accumulated amortization">(186,927</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 7.1pt">Less impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di_c20220401__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zVsLt6udkzM2" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">(324,397</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di0_c20210401__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zAZmmZZRBHIi" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt; padding-left: 7.1pt"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zusSDW1Utnk5" style="font-weight: bold; text-align: right" title="Intangible assets, gross">384,092</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zqd2EwtF67Oc" style="font-weight: bold; text-align: right" title="Intangible assets, gross">897,154</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 12pt; padding-left: 7.1pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"> Software development costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zCP1H4TdbfR5" style="text-align: right" title="Software develpoment costs">655,641</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zl85lhUkM7E6" style="text-align: right" title="Software develpoment costs">583,826</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 7.1pt"> Less impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di_c20220401__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zMVauOKaZCba" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">(655,641</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di0_c20210401__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zdrpntlXdAhl" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt; padding-bottom: 1pt; padding-left: 7.1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_d0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zCH1iW7BPJH8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Intangible assets, gross">—</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zy4ED5wiRxlj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Intangible assets, gross">583,826</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 12pt; padding-bottom: 2.5pt; padding-left: 7.1pt"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20230331_zFpftZEEgpV1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets net">384,092</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20220331_zJ8PSk8Y0Iu3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets net">1,480,980</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Amortization expensed within the consolidated statements of operations and comprehensive loss relating to intangible assets for the years ended March 31, 2023 and 2022 was approximately $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20220401__20230331_pp0p0" title="Amortization expense related to intangible assets">193,000</span> and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20210401__20220331_pp0p0" title="Amortization expense related to intangible assets">92,000</span>, respectively. At March 31, 2023, intangible assets and capitalized software costs have been reduced for impairments of $<span id="xdx_90E_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20220401__20230331_zrnX3asvb6M5" title="Intangible assets impairment">324,397</span> and $<span id="xdx_90D_eus-gaap--CapitalizedComputerSoftwareGross_iI_c20230331_z7Id99GDrgkg" title="Software develpoment costs">655,641</span>, respectively. At March 31, 2022, <span id="xdx_905_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20210401__20220331_zzm2x418YDQ5" title="Intangible assets impairment">no</span> impairments were recorded</p> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p style="font: 10pt Times New Roman, Times, Serif"></p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zturhI381Ed4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><span id="xdx_8B2_zbeBlMaPblI3" style="display: none">Schedule of Intangible Assets</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 8pt"> </td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">March 31,</td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2023<br/></b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2022<br/></b></span></p></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 12pt; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-left: 7.1pt">Patents and licenses</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> $</td><td id="xdx_98B_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zK8eRLjyseAg" style="width: 14%; text-align: right" title="Patents and licenses">1,175,580</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> $</td><td id="xdx_986_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zczaMqQK1Hcl" style="width: 14%; text-align: right" title="Patents and licenses">1,084,081</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Less accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z5aXSs8LAFUh" style="text-align: right" title="Less accumulated amortization">(467,091</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zUMWWhWWKbp7" style="text-align: right" title="Less accumulated amortization">(186,927</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 7.1pt">Less impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di_c20220401__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zVsLt6udkzM2" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">(324,397</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di0_c20210401__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zAZmmZZRBHIi" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt; padding-left: 7.1pt"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zusSDW1Utnk5" style="font-weight: bold; text-align: right" title="Intangible assets, gross">384,092</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zqd2EwtF67Oc" style="font-weight: bold; text-align: right" title="Intangible assets, gross">897,154</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 12pt; padding-left: 7.1pt"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"> Software development costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zCP1H4TdbfR5" style="text-align: right" title="Software develpoment costs">655,641</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zl85lhUkM7E6" style="text-align: right" title="Software develpoment costs">583,826</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left; padding-left: 7.1pt"> Less impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di_c20220401__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zMVauOKaZCba" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">(655,641</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_iN_pp0p0_di0_c20210401__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zdrpntlXdAhl" style="border-bottom: Black 1pt solid; text-align: right" title="Less impairment">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt; padding-bottom: 1pt; padding-left: 7.1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_d0_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zCH1iW7BPJH8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Intangible assets, gross">—</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zy4ED5wiRxlj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Intangible assets, gross">583,826</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 12pt; padding-bottom: 2.5pt; padding-left: 7.1pt"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20230331_zFpftZEEgpV1" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets net">384,092</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20220331_zJ8PSk8Y0Iu3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets net">1,480,980</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 1175580 1084081 467091 186927 324397 -0 384092 897154 655641 583826 655641 -0 0 583826 384092 1480980 193000 92000 324397 655641 0 <p id="xdx_805_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zxA6jOSwfrzb" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 8 – <span id="xdx_821_zWYK5oxcoQT3">DERIVATIVE LIABILITIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Warrant liability </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0; background-color: white">In January 2023, the Company completed an equity offering (see Note 11), which included the issuance of <span id="xdx_904_ecustom--WarrantsIssued_c20230101__20230131_z5JnmStUSqh3" title="Warrants issued">4,796,206</span> warrants. Upon the occurrence of certain transactions (“Fundamental Transactions,” as defined), the warrants provide for a value determined using a Black Scholes model with inputs calculated as described in the warrant agreement which includes a <span id="xdx_908_ecustom--VolatilityInterestRate_dp_c20230101__20230131_zz0ZBMLcAQJk" title="Volatility interest rate">100</span>% floor on the volatility input to be utilized. The Company has determined that this provision introduces leverage to the holders of the warrants that could result in a value that would be greater than the settlement amount of a fixed-for-fixed option on the Company’s own equity shares. Accordingly, pursuant to ASC 815, the Company has classified the fair value of the warrants as a liability to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The warrant liability was valued at the following dates using a Black-Scholes model with the following assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfWarrantLiabilityValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPXwWhCIFvJ6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE LIABILITIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B0_z1Jucoeja0h5" style="display: none">Schedule of warrant liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>January 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>(date issued)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Warrant liability:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.90</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyRGXVUonh4c" title="Risk-free interest rate">3.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqcCnnymAvQa" title="Risk-free interest rate">3.63</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxY49Gew1Ot6" title="Expected volatility">108</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCPdE8cPHLRj" title="Expected volatility">109</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life (in years)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYC7XKasYbeg" title="Expected life (in years)">5.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zd94maxUMFAb" title="Expected life (in years)">5.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpXQ2wem05jh" title="Expected dividend yield">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoOpcHRQtbTg" title="Expected dividend yield">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Fair value of Warrant liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zR9ZBNGaEdPg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--FairValueAdjustmentOfWarrants_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4zoGNMb3RAi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant liability">4,956,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zC28BD2dCuJc" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. Expected volatility was determined based on the historical volatility data of the Company, and the expected term of the warrants granted are determined based on the duration of time the warrants are expected to be outstanding. The dividend yield on the Company’s warrants is assumed to be zero as the Company has not historically paid dividends.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Foreign exchange contract liability </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is exposed to the impact of foreign currency exchange fluctuations as a significant proportion of its expenses are denominated in GBP, and the Company’s cash is in USD and GBP. In February 2021, the Company entered into a forward contract to sell USD and buy GBP. The contract meets the definition of a derivative subject to the guidance of ASC 815, does not qualify for hedge accounting, and accordingly is recognized at fair value, with changes in fair value recognized in earnings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The term of the contract is 25 months, beginning July, 2022, and ending August, 2024. The contract initially had a maximum notional amount of $<span id="xdx_908_eus-gaap--DerivativeLiabilityNotionalAmount_iI_c20220331_zhEhzV5jKVw6" title="Notional amount">6,250,000</span> (and a maximum leveraged amount equal to two times the notional amount, or$<span id="xdx_90D_ecustom--FairValueOfContractLiabilityLeveragedAmounts_iI_c20220331_zL6g0cHfc5Vk" title="Leveraged amount">12,500,000</span>). $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20210401__20220331_zhav2dnVrOW2" title="Contractual notional amount">250,000</span> of the contractual notional amount is settled (expires) each month through August 2024. <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20220401__20230331_z2vcRtPGIWdg" title="Description of conversion terms for debt instrument">On each monthly settlement date, if the USD/GBP spot rate is above $1.359, the Company has the right to convert $250,000 USD into GBP at a fixed rate of $1.359. If the spot rate is between $1.359 and $1.319 on the settlement date, the Company has no obligations, but can convert $250,000 USD into GBP at the spot rate. Finally, if the spot rate is below $1.319 on the settlement date, the Company is obligated to convert $500,000 USD (the settlement date leveraged amount) into GBP at the fixed rate of $1.359. Alternatively, instead of selling $500,000 USD, the Company can pay the difference in the spot rate and the $1.359 exchange rate for $500,000 USD (net settle) to the counterparty.</span> During the year ended March 31, 2023, $<span id="xdx_90F_ecustom--FairValueOfContractLiabilityLeveragedAmountsExpired_iI_c20230331_zn8EAXCP0gzg" title="Leverage leveraged amount">4,000,000</span> of the leveraged amount (and $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220401__20230331_z2l6zjvUpIte" title="Contractual notional amount">2,000,000</span> of the notional amount) expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At March 31, 2023 and 2022, the fair value of the foreign currency contract liability was valued as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfFairValueOfTheForeignCurrencyContractLiabilityTableTextBlock_z5Z0hdZ3C0vl" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE LIABILITIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B5_zY4FzBq7haF8" style="display: none">Schedule of fair value of the foreign currency contract liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">March 31,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Notional amount"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Notional amount"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Notional amount</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilityNotionalAmount_iI_c20230331_zrKoU4DX08V5" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Notional amount">4,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilityNotionalAmount_iI_c20220331_zApmQ1lilaj7" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Notional amount">6,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Leveraged amount (used to determine fair value of contract liability at March 31, 2023 and 2022)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--FairValueOfContractLiabilityLeveragedAmounts_iI_c20230331_z4NfNpznYGv7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leveraged amount (used to determine fair value of contract liability)">8,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--FairValueOfContractLiabilityLeveragedAmounts_iI_c20220331_z1FNsSFoV8Hf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leveraged amount (used to determine fair value of contract liability)">12,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected remaining term (in months)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--FairValueOfContractLiabilitiesExpectedRemainingTerm_dtM_c20220401__20230331_za0mOnsk5oOk" title="Expected remaining term (in months)">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--FairValueOfContractLiabilitiesExpectedRemainingTerm_dtM_c20210401__20220331_zUfLaNHjRsIa" title="Expected remaining term (in months)">25</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Fair Value:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Foreign currency contract liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331_zi82SXbNSmV8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331_z7AtWvhX80Ob" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zKgkSjFvjsug" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s foreign currency forward contracts are measured at fair value on a recurring basis and are classified as Level 2 fair value measurement. As of March 31, 2023, the Company has deposited $<span id="xdx_906_ecustom--DepositOnForeignExchangeContract_iI_c20230331_zO74lhKOMkYl" title="Deposit on foreign exchange contract">909,666</span> as collateral with the counterparty related to the foreign currency forward contract. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif"><b></b></p> 4796206 1 <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfWarrantLiabilityValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPXwWhCIFvJ6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE LIABILITIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B0_z1Jucoeja0h5" style="display: none">Schedule of warrant liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>January 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>(date issued)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Warrant liability:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.90</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zyRGXVUonh4c" title="Risk-free interest rate">3.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqcCnnymAvQa" title="Risk-free interest rate">3.63</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxY49Gew1Ot6" title="Expected volatility">108</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCPdE8cPHLRj" title="Expected volatility">109</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life (in years)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYC7XKasYbeg" title="Expected life (in years)">5.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zd94maxUMFAb" title="Expected life (in years)">5.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpXQ2wem05jh" title="Expected dividend yield">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zoOpcHRQtbTg" title="Expected dividend yield">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Fair value of Warrant liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zR9ZBNGaEdPg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant liability">3,092,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--FairValueAdjustmentOfWarrants_c20230130__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4zoGNMb3RAi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant liability">4,956,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0.0360 0.0363 1.08 1.09 P5Y4M2D P5Y6M 0 0 3092000 4956000 6250000 12500000 250000 On each monthly settlement date, if the USD/GBP spot rate is above $1.359, the Company has the right to convert $250,000 USD into GBP at a fixed rate of $1.359. If the spot rate is between $1.359 and $1.319 on the settlement date, the Company has no obligations, but can convert $250,000 USD into GBP at the spot rate. Finally, if the spot rate is below $1.319 on the settlement date, the Company is obligated to convert $500,000 USD (the settlement date leveraged amount) into GBP at the fixed rate of $1.359. Alternatively, instead of selling $500,000 USD, the Company can pay the difference in the spot rate and the $1.359 exchange rate for $500,000 USD (net settle) to the counterparty. 4000000 2000000 <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfFairValueOfTheForeignCurrencyContractLiabilityTableTextBlock_z5Z0hdZ3C0vl" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DERIVATIVE LIABILITIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B5_zY4FzBq7haF8" style="display: none">Schedule of fair value of the foreign currency contract liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">March 31,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Notional amount"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Notional amount"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 66%; text-align: left">Notional amount</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilityNotionalAmount_iI_c20230331_zrKoU4DX08V5" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Notional amount">4,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilityNotionalAmount_iI_c20220331_zApmQ1lilaj7" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Notional amount">6,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Leveraged amount (used to determine fair value of contract liability at March 31, 2023 and 2022)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--FairValueOfContractLiabilityLeveragedAmounts_iI_c20230331_z4NfNpznYGv7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leveraged amount (used to determine fair value of contract liability)">8,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--FairValueOfContractLiabilityLeveragedAmounts_iI_c20220331_z1FNsSFoV8Hf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leveraged amount (used to determine fair value of contract liability)">12,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected remaining term (in months)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--FairValueOfContractLiabilitiesExpectedRemainingTerm_dtM_c20220401__20230331_za0mOnsk5oOk" title="Expected remaining term (in months)">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--FairValueOfContractLiabilitiesExpectedRemainingTerm_dtM_c20210401__20220331_zUfLaNHjRsIa" title="Expected remaining term (in months)">25</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Fair Value:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Foreign currency contract liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20230331_zi82SXbNSmV8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency contract liability">731,730</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ForeignCurrencyContractsLiabilityFairValueDisclosure_iI_c20220331_z7AtWvhX80Ob" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign currency contract liability">440,196</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> </table> 4250000 6250000 8500000 12500000 P17M P25M 731730 440196 909666 <p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zIOdty76A3K2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>NOTE 9 – <span id="xdx_82C_z7abRKVueXF2">NOTES PAYABLE</span></b></p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfDebtTableTextBlock_zjPALn5xim4j" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span id="xdx_8BA_zFDpCKmwUlE9" style="display: none">Schedule of notes payable</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2023</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2022</span></td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 7.1pt">Note Purchase Agreement 1 (paid off April 2022)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_d0_c20230331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement1Member_zacDqCSqCCMe" style="width: 14%; font-size: 10pt; text-align: right" title="Total notes payable">—</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement1Member_zwsBQ2nmTHqh" style="width: 14%; font-size: 10pt; text-align: right" title="Total notes payable">270,979</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt">Note Purchase Agreement 2</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement2Member_z2n5uOTCSRHe" style="font-size: 10pt; text-align: right" title="Total notes payable">14,772,293</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement2Member_z3d2GnF0osZ4" style="font-size: 10pt; text-align: right" title="Total notes payable">20,241,421</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Note Purchase Agreement 3</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20230331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement3Member_zdT230Lot8ne" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable">6,024,941</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_988_eus-gaap--LongTermDebt_iI_d0_c20220331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement3Member_zmBH0PjPEIa7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">   Total notes payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230331_z1p2rkrgINc5" style="font-size: 10pt; text-align: right" title="Total notes payable">20,797,234</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--DebtInstrumentCarryingAmount_iI_c20220331_zbTCGwtt8qG1" style="font-size: 10pt; text-align: right" title="Total notes payable">20,512,400</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Unamortized debt discount</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20230331_zJTpovpCkDD2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount">(767,083</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20220331_zooCKOEbRMn" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount">(1,323,676</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Notes payable, net of note discounts</p></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20230331_zVMSeHOc5Kc9" style="font-size: 10pt; text-align: right" title="Notes payable, net of note discounts">20,030,151</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20220331_zZTbFG3NCAof" style="font-size: 10pt; text-align: right" title="Balance of notes payable, net of note discounts">19,188,724</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Current portion</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iNI_di_c20230331_zM4uqy6E2Mei" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Current portion">(16,942,500</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_iNI_di_c20220331_zHlfk6srVTHa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Current portion">(19,188,724</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Non-current portion</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20230331_zGd7tWno9GC9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Non-current portion">3,087,651</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebtNoncurrent_iI_d0_c20220331_ze3V5SeUztU6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Non-current portion">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><i>NOTE PURCHASE AGREEMENT 1 (paid off April 2022)</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On April 15, 2020, the Company issued a note payable (“Note Purchase Agreement 1”) to a third-party investor. The note was for $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_zZVeujUukmpf" title="Principal amount">6,015,000</span>, matured on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_pp0p0_dd_c20200414__20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_zfdmWPxKn2Ca" title="Maturity date">April 15, 2022</span>, and was secured by all the assets of the Company. The Company received cash proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200414__20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_zZxNQj3R5c02" title="Cash proceeds">4,675,000</span>, resulting in a discount of $<span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_c20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_zB6J2DN8BU6j" title="Debt discount">1,340,000</span> made up of an original issue discount (“OID”) of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_za2urcNAKo0d" title="Original issue discount">1,000,000</span>, commission of $<span id="xdx_901_eus-gaap--PaymentsForCommissions_pp0p0_c20200414__20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_z9RIE3ACpyA7" title="Commissions paid">325,000</span> that was paid from proceeds, and $<span id="xdx_90C_ecustom--TransactionExpenses_pp0p0_c20200414__20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_zddW087vE7p5" title="Transaction expenses">15,000</span> to cover transaction expenses. In addition, the Company recorded a fee of 0.833% per month, which was in substance interest at an annual rate of approximately <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20200415__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement1Member_zlK4AwxwQ1Yf" title="Interest at an annual rate">10</span>%, that was added to the note principal each month (as payment in kind, or “PIK” interest). The debt less discount and transaction expenses were accreted over the term of the note using the effective interest rate method. Note Purchase Agreement 1 was repaid in April 2022 and replaced by Note Purchase Agreement 3 issued in May 2022 (see below).</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><i>NOTE PURCHASE AGREEMENT 2</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On February 8, 2021, the Company issued a note payable (“Note Purchase Agreement 2”, “Note 2”) to a third-party investor.  The note was for $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_z8IBNLOOVrw3" title="Principal amount">24,015,000</span>, originally matured on <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_pp0p0_dd_c20210207__20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zB9TyQvxeLH6" title="Maturity date">February 9, 2023</span>, and is secured by all the assets of the Company. The Company received cash proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20210207__20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zyKjbNOeqFXj" title="Cash proceeds">18,800,000</span>, resulting in a discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_c20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_z3B9a9H61ahd" title="Debt discount">5,215,000</span> made up of an original issue discount (“OID”) of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zqBRMmIJiR95" title="Original issue discount">4,000,000</span>, commission of $<span id="xdx_900_eus-gaap--PaymentsForCommissions_pp0p0_c20210207__20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_z2JjPdDgrBH9" title="Commissions paid">1,200,000</span> that was paid from proceeds, and $<span id="xdx_90D_ecustom--TransactionExpenses_pp0p0_c20210207__20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zJoOQut9Gn25" title="Transaction expenses">15,000</span> to cover transaction expenses. The Company agreed to make principal payments beginning in August 2021 of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20210207__20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zZx3J0lvol6i" title="Debt instrument periodic payment">400,000</span> monthly, which increased in February 2022 to $<span id="xdx_90C_ecustom--DebtInstrumentIncreasedPeriodicPayment_pp0p0_c20220201__20220228__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zc9JAYO2lIjj" title="Debt instrument increased periodic payment">2,000,000</span> monthly. In addition, the Company is required to accrue a monthly PIK fee equal to 0.833% of the outstanding balance, which is in substance interest at an annual rate of approximately <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_z4lYpsfooCSd" title="Interest at an annual rate">10</span>%, that is added to the note principal each month. The debt less discount and transaction expenses will be accreted over the term of the note using the effective interest rate method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">Note 2 was amended in May 2022 to reduce principal payments from $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220430__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zHqFJXy3A69k" title="Principal amount">2,000,000</span> a month to $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220531__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zjj8mLORMd66" title="Principal amount">500,000</span> a month. Note 2 was amended again in October 2022 to extend the maturity from February 9, 2023 to <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_pp0p0_dd_c20221001__20221031__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zdpvNToIwRNa" title="Maturity date">July 1, 2024</span>, and to increase principal payments to $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20221031__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_z4qRlN3DWDl5" title="Principal amount">1,000,000</span> a month beginning in March 2023. In consideration, the Company agreed to pay aggregate fees of $<span id="xdx_90E_ecustom--AggregateFees_iI_pp0p0_c20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zffL1tQoiNUb" title="Aggregate fees">2,304,539</span> to the investor which were added to the principal balance of Note 2. The Company accounted for the amendments under the debt extinguishment model as the present value of cash flows of Note 2 under the terms of the amendments (the “new” note) was more than 10% different from the present value of the remaining cash flows under the original terms of Note 2 (the “old” note). The fair value of the new note was determined to be $<span id="xdx_905_eus-gaap--DebtInstrumentFairValue_iI_c20230331__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zVv0vjSdaPBi" title="fair value of debt">17,090,513</span>, less the carrying amount of the old note of $<span id="xdx_90F_eus-gaap--FairValueOptionIneligibleItemsAggregateCarryingAmount_iI_c20230331__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zADbEDaLopec" title="Carrying amount of old debt">16,609,176</span>, plus the fees of $<span id="xdx_901_eus-gaap--DebtInstrumentCollateralFee_c20220401__20230331__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zWks2S9ZAjni" title="Debt instruments fees">2,304,539</span>, resulted in a loss on extinguishment of $<span id="xdx_905_eus-gaap--ExtinguishmentOfDebtAmount_pp0p0_c20210207__20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement2Member_zAf4TppQ1pPg" title="Extinguishment debt">2,785,876</span>, which is included in interest expense for the year ended March 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><i>NOTE PURCHASE AGREEMENT 3</i></b> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On May 20, 2022, the Company issued a note payable (“Note Purchase Agreement 3”) with a third-party investor. The note was for $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220520__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zMQeqNiJXfOj" title="Principal amount">6,015,000</span>, matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_pp0p0_dd_c20220519__20220520__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zADh2H8EJanh" title="Maturity date">May 20, 2024</span>, and is secured by all the assets of the Company. The Company received cash proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20220519__20220520__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zsi93HLCdnR9" title="Cash proceeds">4,700,000</span>, resulting in a discount of $<span id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_c20220520__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zP4N1OXnQIK" title="Debt discount">1,315,000 </span>made up of an original issue discount (“OID”) of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20210208__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zSzwFMu4or6d" title="Original issue discount">1,000,000</span>, commission of $<span id="xdx_90C_eus-gaap--PaymentsForCommissions_pp0p0_c20220519__20220520__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_za6t5aa09O1g" title="Commissions paid">300,000 </span>that was paid from proceeds, and $<span id="xdx_907_ecustom--TransactionExpenses_pp0p0_c20220519__20220520__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zSWJbT4VGzs3" title="Transaction expenses">15,000 </span>to cover transaction expenses. In addition, the Company is required to accrue a monthly PIK fee equal to 0.833% of the outstanding balance, which is in substance interest at an annual rate of approximately <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20220520__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zqExBr9vqVIi" title="Interest rate">10</span>%, that is added to the note principal each month. The debt less discount and transaction expenses will be accreted over the term of the note using the effective interest rate method. At March 31, 2023, the remaining debt discount to be amortized was $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20230331__us-gaap--LongtermDebtTypeAxis__custom--SecuredNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreement3Member_zHLp4GcvKJhi" title="Debt discount amortized">767,083</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfDebtTableTextBlock_zjPALn5xim4j" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span id="xdx_8BA_zFDpCKmwUlE9" style="display: none">Schedule of notes payable</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2023</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2022</span></td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 7.1pt">Note Purchase Agreement 1 (paid off April 2022)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LongTermDebt_iI_d0_c20230331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement1Member_zacDqCSqCCMe" style="width: 14%; font-size: 10pt; text-align: right" title="Total notes payable">—</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement1Member_zwsBQ2nmTHqh" style="width: 14%; font-size: 10pt; text-align: right" title="Total notes payable">270,979</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt">Note Purchase Agreement 2</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--LongTermDebt_iI_c20230331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement2Member_z2n5uOTCSRHe" style="font-size: 10pt; text-align: right" title="Total notes payable">14,772,293</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement2Member_z3d2GnF0osZ4" style="font-size: 10pt; text-align: right" title="Total notes payable">20,241,421</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Note Purchase Agreement 3</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebt_iI_c20230331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement3Member_zdT230Lot8ne" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable">6,024,941</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_988_eus-gaap--LongTermDebt_iI_d0_c20220331__us-gaap--DebtInstrumentAxis__custom--NotePurchaseAgreement3Member_zmBH0PjPEIa7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">   Total notes payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230331_z1p2rkrgINc5" style="font-size: 10pt; text-align: right" title="Total notes payable">20,797,234</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--DebtInstrumentCarryingAmount_iI_c20220331_zbTCGwtt8qG1" style="font-size: 10pt; text-align: right" title="Total notes payable">20,512,400</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Unamortized debt discount</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20230331_zJTpovpCkDD2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount">(767,083</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20220331_zooCKOEbRMn" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount">(1,323,676</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Notes payable, net of note discounts</p></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20230331_zVMSeHOc5Kc9" style="font-size: 10pt; text-align: right" title="Notes payable, net of note discounts">20,030,151</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--LongTermDebt_iI_c20220331_zZTbFG3NCAof" style="font-size: 10pt; text-align: right" title="Balance of notes payable, net of note discounts">19,188,724</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Current portion</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iNI_di_c20230331_zM4uqy6E2Mei" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Current portion">(16,942,500</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--LongTermDebtCurrent_iNI_di_c20220331_zHlfk6srVTHa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Current portion">(19,188,724</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Non-current portion</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20230331_zGd7tWno9GC9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Non-current portion">3,087,651</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebtNoncurrent_iI_d0_c20220331_ze3V5SeUztU6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Long term debt, Non-current portion">—</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> </table> 0 270979 14772293 20241421 6024941 0 20797234 20512400 767083 1323676 20030151 19188724 16942500 19188724 3087651 0 6015000 2022-04-15 4675000 1340000 1000000 325000 15000 0.10 24015000 2023-02-09 18800000 5215000 4000000 1200000 15000 400000 2000000 0.10 2000000 500000 2024-07-01 1000000 2304539 17090513 16609176 2304539 2785876 6015000 2024-05-20 4700000 1315000 1000000 300000 15000 0.10 767083 <p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zzcZPlTwLMm7" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 10 – <span id="xdx_827_zu5gF7Kd3w0d">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Nemaura Pharma Limited (“Pharma”), Black and White Health Care Limited (“B&amp;W”) and NDM Technologies Limited (“NDM”) are entities controlled by the Company’s chief executive officer and majority shareholder.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pharma has a service agreement with DDL, to undertake development, manufacture, and regulatory approvals under Pharma’s ISO13485 Accreditation. Pharma invoices DDL on a periodic basis for said services. Services are provided at cost plus a service surcharge amounting to less than 10% of the total costs incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The following is a summary of activity between the Company and Pharma, B&amp;W and NDM for the years ended March 31, 2023 and 2022:</p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zhymtur27CQk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY TRANSACTIONS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><span id="xdx_8B5_z6uIsUGDzIp3" style="display: none">Schedule of related party transactions</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2023<br/></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2022<br/></b></span></p></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 12pt; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Due to/(from) related parties at beginning of year</p></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iS_pp0p0_c20220401__20230331_z1N2IdHf12h6" style="width: 14%; text-align: right" title="Due (to)/from related parties at beginning of year">(101,297</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iS_pp0p0_c20210401__20220331_zJ7l51thvoI2" style="width: 14%; text-align: right" title="Due (to)/from related parties at beginning of year">148,795</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses</p></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--AmountsInvoicedByPharmaToDdlNmAndTclPrimarilyRelatingToResearchAndDevelopmentExpenses_pp0p0_c20220401__20230331_fKDEp_zhubq5Scs9u4" style="text-align: right" title="Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses">4,767,586</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AmountsInvoicedByPharmaToDdlNmAndTclPrimarilyRelatingToResearchAndDevelopmentExpenses_pp0p0_c20210401__20220331_fKDEp_z5fLcHj58AF8" style="text-align: right" title="Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses">3,245,985</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Amounts invoiced by DDL to Pharma</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AmountsInvoicedByDdlToPharma_pp0p0_d0_c20220401__20230331_zWXwCfJGsIN2" style="text-align: right" title="Amounts invoiced by DDL to Pharma">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--AmountsInvoicedByDdlToPharma_iN_pp0p0_di_c20210401__20220331_zf9yBKATkXTe" style="text-align: right" title="Amounts invoiced by DDL to Pharma">(2,495</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Amounts repaid by DDL to Pharma</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AmountsRepaidByDdlToPharma_iN_pp0p0_di_c20220401__20230331_zK5Vh88H9x0c" style="text-align: right" title="Amounts repaid by DDL to Pharma">(3,773,217</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--AmountsRepaidByDdlToPharma_iN_pp0p0_di_c20210401__20220331_zTwlMe5wJ1Ve" style="text-align: right" title="Amounts repaid by DDL to Pharma">(3,492,962</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Foreign exchange differences</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ForeignCurrencyTranslationRelatedParty_pp0p0_c20220401__20230331_zE3ifkd3oh6l" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign exchange differences">27,708</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ForeignCurrencyTranslationRelatedParty_iN_pp0p0_di_c20210401__20220331_zBZj8ygSxQgk" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign exchange differences">(620</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Due to/(from) related parties at end of year</p></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iE_pp0p0_c20220401__20230331_zVJRTUrWpl21" style="border-bottom: Black 2.5pt double; text-align: right" title="Due (to)/from related parties at end of year">920,780</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iE_pp0p0_c20210401__20220331_zNOu2MCxYJXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Due (to)/from related parties at end of year">(101,297</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zhymtur27CQk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY TRANSACTIONS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><span id="xdx_8B5_z6uIsUGDzIp3" style="display: none">Schedule of related party transactions</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2023<br/></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 8pt"><b>2022<br/></b></span></p></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 12pt; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="vertical-align: bottom; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Due to/(from) related parties at beginning of year</p></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iS_pp0p0_c20220401__20230331_z1N2IdHf12h6" style="width: 14%; text-align: right" title="Due (to)/from related parties at beginning of year">(101,297</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iS_pp0p0_c20210401__20220331_zJ7l51thvoI2" style="width: 14%; text-align: right" title="Due (to)/from related parties at beginning of year">148,795</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses</p></td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--AmountsInvoicedByPharmaToDdlNmAndTclPrimarilyRelatingToResearchAndDevelopmentExpenses_pp0p0_c20220401__20230331_fKDEp_zhubq5Scs9u4" style="text-align: right" title="Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses">4,767,586</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AmountsInvoicedByPharmaToDdlNmAndTclPrimarilyRelatingToResearchAndDevelopmentExpenses_pp0p0_c20210401__20220331_fKDEp_z5fLcHj58AF8" style="text-align: right" title="Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses">3,245,985</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Amounts invoiced by DDL to Pharma</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AmountsInvoicedByDdlToPharma_pp0p0_d0_c20220401__20230331_zWXwCfJGsIN2" style="text-align: right" title="Amounts invoiced by DDL to Pharma">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--AmountsInvoicedByDdlToPharma_iN_pp0p0_di_c20210401__20220331_zf9yBKATkXTe" style="text-align: right" title="Amounts invoiced by DDL to Pharma">(2,495</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Amounts repaid by DDL to Pharma</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--AmountsRepaidByDdlToPharma_iN_pp0p0_di_c20220401__20230331_zK5Vh88H9x0c" style="text-align: right" title="Amounts repaid by DDL to Pharma">(3,773,217</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--AmountsRepaidByDdlToPharma_iN_pp0p0_di_c20210401__20220331_zTwlMe5wJ1Ve" style="text-align: right" title="Amounts repaid by DDL to Pharma">(3,492,962</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Foreign exchange differences</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ForeignCurrencyTranslationRelatedParty_pp0p0_c20220401__20230331_zE3ifkd3oh6l" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign exchange differences">27,708</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ForeignCurrencyTranslationRelatedParty_iN_pp0p0_di_c20210401__20220331_zBZj8ygSxQgk" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign exchange differences">(620</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">Due to/(from) related parties at end of year</p></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iE_pp0p0_c20220401__20230331_zVJRTUrWpl21" style="border-bottom: Black 2.5pt double; text-align: right" title="Due (to)/from related parties at end of year">920,780</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--RelatedPartyTransactionDueFromToRelatedParties_iE_pp0p0_c20210401__20220331_zNOu2MCxYJXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Due (to)/from related parties at end of year">(101,297</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> -101297 148795 4767586 3245985 0 2495 3773217 3492962 27708 620 920780 -101297 <p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zFflUrXQ3mHe" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>NOTE 11 – <span id="xdx_82C_zDrLipkdLgJh">INCOME TAXES</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company and its subsidiaries file separate income tax returns.</p> <p style="font: 10pt Times New Roman, Times, Serif"><b>United States of America</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company is incorporated in the U.S. and is subject to a U.S. federal corporate income tax rate of <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220401__20230331__srt--StatementGeographicalAxis__country--US_zRxvWQ5nFe7c" title="Income tax rate">21</span>% for the year ended March 31, 2023 and <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210401__20220331__srt--StatementGeographicalAxis__country--US_zMWE6aN8vk74" title="Income tax rate">21</span>% for the year ended March 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>British Virgin Islands</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">RGL was incorporated in the British Virgin Islands (“BVI”). Under the current laws of the BVI, RGL was not subject to tax on income or capital gains. In addition, upon payments of dividends by RGL, no BVI withholding tax was imposed. During the years ended March 31, 2022 and 2021, there were no income or expenses in the BVI; RGL was formally dissolved as of April 23, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>UK</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">DDL, TCL and DDHL are all incorporated in the UK and the applicable UK statutory income tax rate for these companies is <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220401__20230331__srt--StatementGeographicalAxis__country--GB_zaWaeb6Hb0Eb" title="Income tax rate">19</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">For the fiscal years ended March 31, 2023 and 2022 loss before income tax benefit arose in the UK and U.S. as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zGqIgHSMsri3" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span id="xdx_8B8_zOtS8hcJklWc" style="display: none">Schedule of loss before income tax</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_497_20220401__20230331_zZ7hF6zu9wXb" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_492_20210401_20220331" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2023</span></p> <p style="margin-top: 0; margin-bottom: 0"></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2022</span></p> <p style="margin-top: 0; margin-bottom: 0"></p></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 7.1pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><b></b></span></td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; text-align: right"></td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zIRqBZzJOt4a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 7.1pt">Loss before income taxes arising in UK</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$ </td><td style="width: 14%; font-size: 10pt; text-align: right">(13,314,440</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$ </td><td style="width: 14%; font-size: 10pt; text-align: right">(11,716,916</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zdBkDJorsFUc" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Loss before income taxes arising in U.S.</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(829,295</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,520,145</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossAttributableToParent_zGSiauuPKp7l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt"><span style="font-size: 10pt">Total loss before income tax benefit</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(14,143,735</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">) </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(14,237,061</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p style="font: 10pt Times New Roman, Times, Serif">Reconciliation of our effective tax rate to the loss calculated at the statutory U.S. federal tax rate is as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEXKoAY1umU7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><span id="xdx_8BF_zcDrHrXw1Yfi" style="display: none">Reconciliation of effective tax rate</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="15" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>March 31,</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; padding-left: 7.1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center" title="Loss before income taxes"><span style="font-size: 8pt"><b>2022</b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt"><span style="font-size: 10pt">Loss before income taxes</span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_983_ecustom--LossBeforeIncomeTaxes_pp0p0_c20220401__20230331_zWinURD0qtT3" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Loss before income taxes">(14,143,735</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)<span style="font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; width: 10%; text-align: right"><span style="font-size: 10pt"></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"></span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left">$ </td><td id="xdx_981_ecustom--LossBeforeIncomeTaxes_pp0p0_c20210401__20220331_zcu1uWFjael6" style="border-bottom: Black 1pt solid; text-align: right" title="Loss before income taxes">(14,237,061</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; width: 1%; font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; width: 10%; font-size: 12pt; text-align: right"></td><td style="width: 1%; padding-bottom: 1pt; font-size: 12pt; text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Expected tax benefit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20220401__20230331_ziRlZRuln5ul" style="text-align: right" title="Expected tax benefit">(3,145,943</td><td style="text-align: left">)</td><td></td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_c20220401__20230331_zKmhosZK1pFj" title="Expected tax benefit, Percentage">(22</span></p></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20210401__20220331_zQxpS37Eixzk" style="text-align: right" title="Expected tax benefit">(2,989,783</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_c20210401__20220331_zSgyxFAHgkva" title="Expected tax benefit, Percentage">(21</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Foreign tax differential</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c20220401__20230331_pp0p0" style="text-align: right" title="Foreign tax differential"> 235,938</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20220401__20230331_zzTjyHk2IoJ8" title="Foreign tax differential, Percentage">2</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_pp0p0_c20210401__20220331_z2JtJLPfdtb8" style="text-align: right" title="Foreign tax differential">234,338</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20210401__20220331_ze6JFUsmQTFb" title="Foreign tax differential, Percentage">2</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Enhanced research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pp0p0_di_c20220401__20230331_zHVPo8MT3P5g" style="text-align: right" title="Enhanced research and development">(369,946</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_dp_c20220401__20230331_zhLUiDW5NYGa" title="Enhanced research and development, Percentage">(3</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pp0p0_di_c20210401__20220331_zRGQHgYqVkn6" style="text-align: right" title="Enhanced research and development">(463,591</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_dp_c20210401__20220331_zwf5FsFAGFfi" title="Enhanced research and development, Percentage">(3</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Prior year true-up of NOL’s</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--PriorYearTrueupOfNols_pp0p0_c20220401__20230331_zVuNTaROj9O2" style="text-align: right" title="Prior year true up of nol">(46,393</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_907_ecustom--IncomeTaxReconciliationPriorYearTrueupOfNols_dp_c20220401__20230331_zexGVzbpdX61" title="Prior year true up of nol, Percentage">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--PriorYearTrueupOfNols_pp0p0_c20210401__20220331_zGdNEcIo3sX8" style="text-align: right" title="Prior year true up of nol">2,401,930</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--IncomeTaxReconciliationPriorYearTrueupOfNols_dp_c20210401__20220331_z9j7EGzTQ0h5" title="Prior year true up of nol, Percentage">17</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt">Other</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--IncomeTaxReconciliationOtherAdjustments_c20220401__20230331_pp0p0" style="text-align: right" title="Other"> 338,278</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220401__20230331_zWrOwYB6Ef8" title="Other, Percentage">2</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pp0p0_c20210401__20220331_z5JjpbIub8Gi" style="text-align: right" title="Other">74,579</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20210401__20220331_zOeBw75lF4c" title="Other, Percentage">1</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220401__20230331_pp0p0" style="text-align: right" title="Change in valuation allowance">2,988,066</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220401__20230331_z2JCrdJz0ueb" title="Change in valuation allowance, Percentage">21</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_c20210401__20220331_zdIHbnGnBua8" style="text-align: right" title="Change in valuation allowance">742,527</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210401__20220331_zH3pPHzOC7ka" title="Change in valuation allowance, Percentage">5</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">R&amp;D credit received</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--RdCreditReceived_pp0p0_d0_c20220401__20230331_zehAr6KOt97k" style="border-bottom: Black 1pt solid; text-align: right" title="R&amp;D credit received">—</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--IncomeTaxReconciliationRdCreditReceived_dp0_c20220401__20230331_zMmdVATJ8cMi" title="R&amp;D credit received, Percentage">—</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--RdCreditReceived_pp0p0_c20210401__20220331_zHAYDPZ4Bc7h" style="border-bottom: Black 1pt solid; text-align: right" title="R&amp;D credit received">350,256</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--IncomeTaxReconciliationRdCreditReceived_dp_c20210401__20220331_zfWgyc2AnSd8" title="R&amp;D credit received, Percentage">2</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt">Actual income tax benefit</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$ </td><td id="xdx_989_eus-gaap--CurrentIncomeTaxExpenseBenefit_pp0p0_d0_c20220401__20230331_zjFpDRjUgG48" style="border-bottom: Black 2.5pt double; text-align: right" title="Actual income tax benefit">—</td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20220401__20230331_zwthTDeN7Or9" title="Income tax benefit, Percentage">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$ </td><td id="xdx_983_eus-gaap--CurrentIncomeTaxExpenseBenefit_pp0p0_c20210401__20220331_z7JvTzX85yj" style="border-bottom: Black 2.5pt double; text-align: right" title="Actual income tax benefit">350,256</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210401__20220331_zSsQBxDNZ4ug" title="Income tax benefit, Percentage">2</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The tax effects of the temporary differences that give rise to significant portions of deferred income tax assets are presented below:</p> <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zfn6aDIISz09" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span id="xdx_8BF_zUALSBGi7TKf" style="display: none">Schedule of deferred income tax assets</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20230331_zpVMwtT42yA9" style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_494_20220331_zrswWlk35ALg" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2023</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 7.1pt"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b></b></span></td><td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zPTsReYV2W8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 7.1pt"><span style="font-size: 10pt">Net operating tax loss carried forward</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="width: 14%; text-align: right"><span style="font-size: 10pt">9,259,000 </span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="width: 14%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">6,671,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--ResearchAndDevelopmentEnhancement_iI_zvqLjjuYGZ0g" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span style="font-size: 10pt">Research and development enhancement</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> 361,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">335,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_ecustom--OtherItems_iI_zlUfOILRfPAl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span style="font-size: 10pt">Other items</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> 38,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(335,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zBHQLy6jf3zg" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt"><span style="font-size: 10pt">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"> (9,658,000</span></td><td style="padding-bottom: 1pt; text-align: left">)<span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(6,671,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iI_d0_zubpzOkerEn" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt"><span style="font-size: 10pt">Net deferred tax assets</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In the fiscal year ended March 31, 2023, the Company received <span id="xdx_901_eus-gaap--IncomeTaxReconciliationTaxCreditsOther_pp0p0_do_c20220401__20230331_zmTBvsd66pn8" title="HMRC tax credit">no</span> reimbursement from HMRC (Her Majesty’s Revenue and Customs) in tax credits relating to research and development expenses incurred during the fiscal year ended March 31, 2022. In the fiscal year ended March 31, 2022, the Company received $<span id="xdx_90F_eus-gaap--IncomeTaxReconciliationTaxCreditsOther_pp0p0_c20210401__20220331_z170sC810Xk7" title="HMRC tax credit">350,256</span> from HMRC in tax credits relating to the reimbursement of research and development expenses incurred during the fiscal year ended March 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">For each of the fiscal years ended March 31, 2023 and 2022, the Company did not have unrecognized tax benefits, and therefore no interest or penalties related to unrecognized tax benefits were accrued. Management does not expect that the amount of unrecognized tax benefits will change significantly within the next twelve months.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company mainly files income tax returns in the U.S. and the UK. The Company is subject to U.S. federal income tax examination by tax authorities for tax years beginning in 2019.  The UK tax returns for the Company’s UK subsidiaries are open to examination by the UK tax authorities for the tax years beginning April 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">As of March 31, 2023, the Company has net operating losses (“NOLs”) of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_c20230331__srt--StatementGeographicalAxis__country--US_ziPx5Dlki2qd" title="Net operating losses">11,300,000</span> in the U.S. and $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20230331__srt--StatementGeographicalAxis__country--GB_zS9IUJ1nBCcb" title="Net operating losses">36,230,000</span> in the UK. NOLs may be carried forward indefinitely. Additionally, the Company has a research and development enhancement deduction carry forward of approximately $<span id="xdx_908_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_c20220401__20230331__srt--StatementGeographicalAxis__country--GB_zmcpNGocnSyc" title="Research and development">1,899,000</span> for purposes of UK income tax filings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2.85pt 8.35pt 0; text-align: justify"></p> 0.21 0.21 0.19 <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zGqIgHSMsri3" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span id="xdx_8B8_zOtS8hcJklWc" style="display: none">Schedule of loss before income tax</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_497_20220401__20230331_zZ7hF6zu9wXb" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_492_20210401_20220331" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2023</span></p> <p style="margin-top: 0; margin-bottom: 0"></p></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2022</span></p> <p style="margin-top: 0; margin-bottom: 0"></p></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 7.1pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 10pt"><b></b></span></td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; text-align: right"></td><td style="font-size: 10pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zIRqBZzJOt4a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 7.1pt">Loss before income taxes arising in UK</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$ </td><td style="width: 14%; font-size: 10pt; text-align: right">(13,314,440</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$ </td><td style="width: 14%; font-size: 10pt; text-align: right">(11,716,916</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zdBkDJorsFUc" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">Loss before income taxes arising in U.S.</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(829,295</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,520,145</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--IncomeLossAttributableToParent_zGSiauuPKp7l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt"><span style="font-size: 10pt">Total loss before income tax benefit</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(14,143,735</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">) </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(14,237,061</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> </table> -13314440 -11716916 -829295 -2520145 -14143735 -14237061 <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEXKoAY1umU7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt"><span id="xdx_8BF_zcDrHrXw1Yfi" style="display: none">Reconciliation of effective tax rate</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="15" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>March 31,</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; padding-left: 7.1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b>2023</b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center" title="Loss before income taxes"><span style="font-size: 8pt"><b>2022</b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 8pt"><b> </b></span></td> <td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 12pt; text-align: center"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt"><span style="font-size: 10pt">Loss before income taxes</span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_983_ecustom--LossBeforeIncomeTaxes_pp0p0_c20220401__20230331_zWinURD0qtT3" style="border-bottom: Black 1pt solid; width: 10%; text-align: right" title="Loss before income taxes">(14,143,735</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)<span style="font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; width: 10%; text-align: right"><span style="font-size: 10pt"></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"></span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left">$ </td><td id="xdx_981_ecustom--LossBeforeIncomeTaxes_pp0p0_c20210401__20220331_zcu1uWFjael6" style="border-bottom: Black 1pt solid; text-align: right" title="Loss before income taxes">(14,237,061</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; width: 1%; font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; width: 10%; font-size: 12pt; text-align: right"></td><td style="width: 1%; padding-bottom: 1pt; font-size: 12pt; text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Expected tax benefit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20220401__20230331_ziRlZRuln5ul" style="text-align: right" title="Expected tax benefit">(3,145,943</td><td style="text-align: left">)</td><td></td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_c20220401__20230331_zKmhosZK1pFj" title="Expected tax benefit, Percentage">(22</span></p></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_c20210401__20220331_zQxpS37Eixzk" style="text-align: right" title="Expected tax benefit">(2,989,783</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_c20210401__20220331_zSgyxFAHgkva" title="Expected tax benefit, Percentage">(21</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Foreign tax differential</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c20220401__20230331_pp0p0" style="text-align: right" title="Foreign tax differential"> 235,938</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20220401__20230331_zzTjyHk2IoJ8" title="Foreign tax differential, Percentage">2</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_pp0p0_c20210401__20220331_z2JtJLPfdtb8" style="text-align: right" title="Foreign tax differential">234,338</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20210401__20220331_ze6JFUsmQTFb" title="Foreign tax differential, Percentage">2</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 7.1pt">Enhanced research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pp0p0_di_c20220401__20230331_zHVPo8MT3P5g" style="text-align: right" title="Enhanced research and development">(369,946</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_dp_c20220401__20230331_zhLUiDW5NYGa" title="Enhanced research and development, Percentage">(3</span></td><td style="text-align: left">%)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pp0p0_di_c20210401__20220331_zRGQHgYqVkn6" style="text-align: right" title="Enhanced research and development">(463,591</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_dp_c20210401__20220331_zwf5FsFAGFfi" title="Enhanced research and development, Percentage">(3</span></td><td style="text-align: left">%)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Prior year true-up of NOL’s</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--PriorYearTrueupOfNols_pp0p0_c20220401__20230331_zVuNTaROj9O2" style="text-align: right" title="Prior year true up of nol">(46,393</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_907_ecustom--IncomeTaxReconciliationPriorYearTrueupOfNols_dp_c20220401__20230331_zexGVzbpdX61" title="Prior year true up of nol, Percentage">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--PriorYearTrueupOfNols_pp0p0_c20210401__20220331_zGdNEcIo3sX8" style="text-align: right" title="Prior year true up of nol">2,401,930</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--IncomeTaxReconciliationPriorYearTrueupOfNols_dp_c20210401__20220331_z9j7EGzTQ0h5" title="Prior year true up of nol, Percentage">17</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt">Other</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--IncomeTaxReconciliationOtherAdjustments_c20220401__20230331_pp0p0" style="text-align: right" title="Other"> 338,278</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20220401__20230331_zWrOwYB6Ef8" title="Other, Percentage">2</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pp0p0_c20210401__20220331_z5JjpbIub8Gi" style="text-align: right" title="Other">74,579</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_c20210401__20220331_zOeBw75lF4c" title="Other, Percentage">1</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7.1pt">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220401__20230331_pp0p0" style="text-align: right" title="Change in valuation allowance">2,988,066</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220401__20230331_z2JCrdJz0ueb" title="Change in valuation allowance, Percentage">21</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_c20210401__20220331_zdIHbnGnBua8" style="text-align: right" title="Change in valuation allowance">742,527</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210401__20220331_zH3pPHzOC7ka" title="Change in valuation allowance, Percentage">5</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 7.1pt">R&amp;D credit received</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--RdCreditReceived_pp0p0_d0_c20220401__20230331_zehAr6KOt97k" style="border-bottom: Black 1pt solid; text-align: right" title="R&amp;D credit received">—</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_ecustom--IncomeTaxReconciliationRdCreditReceived_dp0_c20220401__20230331_zMmdVATJ8cMi" title="R&amp;D credit received, Percentage">—</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--RdCreditReceived_pp0p0_c20210401__20220331_zHAYDPZ4Bc7h" style="border-bottom: Black 1pt solid; text-align: right" title="R&amp;D credit received">350,256</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_ecustom--IncomeTaxReconciliationRdCreditReceived_dp_c20210401__20220331_zfWgyc2AnSd8" title="R&amp;D credit received, Percentage">2</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt">Actual income tax benefit</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$ </td><td id="xdx_989_eus-gaap--CurrentIncomeTaxExpenseBenefit_pp0p0_d0_c20220401__20230331_zjFpDRjUgG48" style="border-bottom: Black 2.5pt double; text-align: right" title="Actual income tax benefit">—</td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20220401__20230331_zwthTDeN7Or9" title="Income tax benefit, Percentage">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$ </td><td id="xdx_983_eus-gaap--CurrentIncomeTaxExpenseBenefit_pp0p0_c20210401__20220331_z7JvTzX85yj" style="border-bottom: Black 2.5pt double; text-align: right" title="Actual income tax benefit">350,256</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210401__20220331_zSsQBxDNZ4ug" title="Income tax benefit, Percentage">2</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> -14143735 -14237061 -3145943 0.22 -2989783 0.21 235938 0.02 234338 0.02 369946 -0.03 463591 -0.03 -46393 0 2401930 0.17 338278 0.02 74579 0.01 2988066 0.21 742527 0.05 0 0 350256 0.02 0 0 350256 0.02 <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zfn6aDIISz09" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span id="xdx_8BF_zUALSBGi7TKf" style="display: none">Schedule of deferred income tax assets</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20230331_zpVMwtT42yA9" style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_494_20220331_zrswWlk35ALg" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">March 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2023</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 7.1pt"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td><td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b></b></span></td><td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zPTsReYV2W8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 7.1pt"><span style="font-size: 10pt">Net operating tax loss carried forward</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="width: 14%; text-align: right"><span style="font-size: 10pt">9,259,000 </span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="width: 14%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">6,671,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--ResearchAndDevelopmentEnhancement_iI_zvqLjjuYGZ0g" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span style="font-size: 10pt">Research and development enhancement</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> 361,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">335,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_ecustom--OtherItems_iI_zlUfOILRfPAl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 7.1pt"><span style="font-size: 10pt">Other items</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> 38,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(335,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zBHQLy6jf3zg" style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 7.1pt"><span style="font-size: 10pt">Valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"> (9,658,000</span></td><td style="padding-bottom: 1pt; text-align: left">)<span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(6,671,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iI_d0_zubpzOkerEn" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 7.1pt"><span style="font-size: 10pt">Net deferred tax assets</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$ </span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 9259000 6671000 361000 335000 38000 -335000 9658000 6671000 0 0 0 350256 11300000 36230000 1899000 <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zwjOz9VyrPu7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>NOTE 12 – <span id="xdx_82E_zntmDiyWBEB1">STOCKHOLDERS’ EQUITY</span></b></p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; text-align: justify">The Company filed a shelf registration statement on Form S-3 with the SEC, which was declared effective by the SEC on March 24, 2022 (the “2022 Shelf Registration Statement”). The 2022 Shelf Registration Statement provides the Company with the ability to issue common stock and other securities as described in the registration statement from time to time up to an aggregate amount of $<span id="xdx_905_ecustom--AggregateAmount_iI_pn3n3_dm_c20220324_zHjHqHC7HCw7" title="Aggregate amount">224.6</span> million, dependent upon available shares.</p> <p style="font: 10pt/11.5pt Times New Roman, Times, Serif; text-align: justify">In January 2023, Armistice Capital LLC and Alyeska Master Fund LLC agreed to buy a total of <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20230101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember_z0qBQBS4ArH9" title="Number of shares purchased">4,796,206 </span>shares of common stock at $<span id="xdx_909_eus-gaap--SharePrice_iI_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember_zt6RrfEwVzRj" title="Share price">1.75</span> per share plus warrants to purchase <span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_c20230101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember_zGwJMoVFxInl" title="Number of shares purchased">4,796,206 </span>shares of common stock with an exercise price equal to $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230131__dei--LegalEntityAxis__custom--ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zF1B8rRF1VJ3" title="Exercise price">2.00</span> per share The gross proceeds totaled $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20230101__20230131__dei--LegalEntityAxis__custom--ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember_zZ4svE8bHTp3" title="Gross proceeds total">8,393,361</span> before costs of $<span id="xdx_906_ecustom--CostsDeductedInRelationToEquityFinancing_pp0p0_c20230101__20230131__dei--LegalEntityAxis__custom--ArmisticeCapitalLLCAndAlyeskaMasterFundLLCMember_zwG97bQE12Pe" title="Costs deducted in relation to equity financing">737,385</span> were deducted.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On July 23, 2021, the Company entered into an At The Market Offering Agreement (the “2021 ATM”) with H.C. Wainwright &amp; Co., LLC pursuant to which the Company may offer and sell from time to time to, at its option, up to an aggregate of $100 million of shares (amended to $<span id="xdx_90C_ecustom--AggregateSharesPriceValue_iI_pn3n3_dm_c20210402__us-gaap--TypeOfArrangementAxis__custom--MarketOfferingAgreementMember__dei--LegalEntityAxis__custom--HCWainwrightAndCoLLCMember_zKHlSJjSSPsd" title="Aggregate shares price value">3</span> million as at April 1, 2022) in of its common stock. </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the year ended March 31, 2022, the Company issued and sold <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketofferingAgreementMember_zHd4liu4Nu4a" title="Number of common stock sold">397,524</span> shares of its common stock (including <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210401__20220331__dei--LegalEntityAxis__custom--TigerTradingPartnersLLCMember_z6HKx7awnsmj" title="Number of common stock sold">375,000</span> shares to Tiger Trading Partners L.L.C., see below) at an average price of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20220331__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketofferingAgreementMember_z9RoTfaH96jf">4.07</span> per share under the 2021 ATM for aggregate net proceeds of $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_dm_c20210401__20220331_zvshJq7aRRr" title="Aggregate net proceeds">1.6</span> million after deducting commissions and offering expenses payable by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the year ended March 31, 2022, the Company agreed to sell <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210401__20220331__dei--LegalEntityAxis__custom--TigerManagementLLCMember_zMcjpiZlVgWd" title="Number of common stock sold">750,000</span> shares to Tiger Trading Partners L.L.C. (an affiliate of Tiger Management L.L.C. (a vehicle for the family office of Julian H. Robertson) at a price of $<span id="xdx_90A_eus-gaap--SharePrice_iI_c20220331__dei--LegalEntityAxis__custom--TigerManagementLLCMember_zY6dY8mU8fzd" title="Share price">4</span> per share and gross proceeds of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_dm_c20210401__20220331__dei--LegalEntityAxis__custom--TigerManagementLLCMember_zMKp51186jL5" title="Gross proceeds">3</span> million; <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210401__20220331__us-gaap--TypeOfArrangementAxis__custom--ATMFacility2021Member_zhYpX2fSrgs5" title="Sale of stock">375,000</span> of the shares were sold within the 2021 ATM facility noted above, and <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220209__20220210__us-gaap--TypeOfArrangementAxis__custom--ATMFacility2021Member_zlOFspere9Oc" title="Sale of stock">375,000</span> of the shares were sold in a direct issuance completed on February 10, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>Stock options</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">A summary of option activity for the years ended March 31, 2023 and 2022 is presented below:</p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zcPPdoySPaV3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B0_zY3Y7bslZjw6" style="display: none">Schedule of option award activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted Average Exercise Price </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weight Average remaining Contractual Term (years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Balance at April 1, 2021</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmKwglGkGIUj" style="text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0AjFOcnP7H4" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 49%; text-align: justify"><span style="font-size: 10pt">Granted</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOpDmb7KcBb" style="width: 14%; text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">40,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> $</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqEI9Nrlr6Ai" style="vertical-align: bottom; width: 14%; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt">3.98</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; width: 14%; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zr9Tv7lBpOR4" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXnFj9tqiLDg" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQe0yydcIOdf" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGFttaSORoPi" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGU7HjKKY7Sd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0jY675dx3M8" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1077">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 11pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Balance at March 31, 2022</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4jGw1alxpj" style="text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">40,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxUFV4OL3Fz6" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt">3.98</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOhKXs5TgPck" title="Weight Average remaining Contractual Term (years)">4.83</span> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk4mpz05vw7h" style="text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzNsLdZB04rd" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z62DZvqNh12a" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCtyONqkR4lk" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zToS40r9JTKj" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1lwPtY9R95e" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPpbZjUIWUz8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zp2Pd9NJsQGk" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-size: 10pt">Balance at March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxcv5f3YTKg1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding ending"><span style="font-size: 10pt">40,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1JDdpsucfTj" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Outstanding ending"><span style="font-size: 10pt">3.98</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJWEneuOrrzl" style="font-size: 10pt" title="Weight Average remaining Contractual Term (years)">2.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vested and exercisable at March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zs7oUAEPgypj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested and exercisable"><span style="font-size: 10pt">40,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjAtygZMkuR2" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Vested and exercisable"><span style="font-size: 10pt">3.98</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwtYgxrijqDf" style="font-size: 10pt" title="Weight Average remaining Contractual Term (years), Vested and exercisable">2.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_znJ1yjsTRX0c" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">No stock options were granted during the fiscal year ended March 31, 2023.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">On January 28, 2022, the Board of Directors granted its directors options to purchase <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220127__20220128__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPVmfC2KEda6" title="Options granted">40,000</span> shares of common stock at an exercise price of $<span id="xdx_904_eus-gaap--SharePrice_iI_c20220128__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0dcQGlHph98" title="Exercise price">3.98</span> per share, which was the closing price of the Company’s common stock on the date of grant. The options were fully vested at grant and are exercisable for a period of five years from the date of grant. The fair value of the stock options was determined to be $<span id="xdx_902_ecustom--FairValueOfStockOptions_iI_pp0p0_c20220128__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX34kxlPB0tk" title="Fair value of stock options">133,529</span> using a Black-Scholes Option Pricing Model with the following assumptions:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zNCL2ldjmsq9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span id="xdx_8BF_z4RQeTKTDZrg" style="display: none">Schedule of key assumptions</span></td> <td style="padding-left: 7.1pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 73%; padding-left: 7.1pt"><span style="font-size: 10pt">Stock Price</span></td> <td style="width: 27%; padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt">$<span id="xdx_906_eus-gaap--SharePrice_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znvphghWON93" title="Stock Price">3.98</span></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Exercise Price</span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvYlMTKLbzKd" title="Exercise Price">3.98</span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Term </span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuJ05Y9bKnPc" title="Term">5</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Volatility </span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQSRWPIvi5xl" title="Volatility">122.52</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Expected dividend yield (%)</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrhXmh0ZPQsa" style="padding-left: 7.1pt; text-align: right" title="Expected dividend yield"><span style="font-size: 10pt">—</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Discount Rate (Bond Equivalent Yield)</span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_dp_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBIPmZ3vwOc5" title="Discount Rate (Bond Equivalent Yield)">2.28</span>%</span></td></tr> </table> <p id="xdx_8A9_zOuyhc030kVk" style="font: 10pt Times New Roman, Times, Serif"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif"><b>Stock Warrants</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify">A summary of warrant activity for the years ended March 31, 2023 and 2022 is presented below:</p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zL0d6cVMxuq7" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8BF_zNJLOZhbvEp5" style="display: none">Schedule of warrant activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted Average Exercise Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weight Average remaining Contractual Term (years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 49%; text-align: justify"><span style="font-size: 10pt">Balance at April 1, 2021</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZQfqEjzPZy6" style="width: 14%; text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">1,939,990</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHCH7e050QM4" style="vertical-align: bottom; width: 14%; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt; color: Black">6.30</span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; width: 14%; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5P2mrSufM5b" title="Weight Average remaining Contractual Term (years)">4.62</span></span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSEw0XuYtktk" style="text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center">—</td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCPzYB0fXAFb" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">(366,892</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zo7erOYWsTo" style="vertical-align: bottom; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt; color: Black">8.08</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0X7Allt4KK1" title="Weight Average remaining Contractual Term (years) exercised">4.08</span></span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlHWkUPYQEFk" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt">  </span>—</td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4kJLsFHq5Pg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black">  </span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt">  </span>—</td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Balance at March 31, 2022</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zP4j7HR0Ja0a" style="text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">1,573,098</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1UbfWzQ9CHi" style="vertical-align: bottom; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt; color: Black">6.64</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztlwYxMXd7q8" title="Weight Average remaining Contractual Term (years)">4.07</span></span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zehP6I99EN1i" style="text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">4,796,206</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFYB1qkCERc4" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt; color: Black">2.00</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQpJ4Za7nIs" title="Weight Average remaining Contractual Term (years) granted">5.00</span></span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkdANfUQtfd9" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt">—</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zw4GagQNxR0e" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt">—</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQSCpKUBAF3k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQJi74Fg8XN4" style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Expired"><span style="font-size: 10pt">5.00</span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Balance at March 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLmTR854x8t1" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Outstanding ending"><span style="font-size: 10pt">6,369,304</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znU0uNvMJORc" style="vertical-align: bottom; color: rgb(204,238,255); padding-bottom: 1pt; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Outstanding ending"><span style="font-size: 10pt; color: Black">2.7</span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2xQtz7HNv2a" title="Weight Average remaining Contractual Term (years)">4.87</span></span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vested and exercisable at March 31, 2023</span></td><td style="font-size: 11pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9L00hOHsVEc" style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: right" title="Number of Options, Vested and exercisable"><span style="font-size: 10pt">6,369,304</span></td><td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7LI2cuS4xV7" style="vertical-align: bottom; padding-bottom: 2.5pt; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price Vested and exercisable"><span style="font-size: 10pt">2.7</span></td><td style="font-size: 11pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 2.5pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAnJikrbFd9h" title="Weight Average remaining Contractual Term (years), Vested and exercisable">4.87</span></span></td></tr> </table> <p id="xdx_8B9_zVd46FF7xHP9" style="font: 10pt Times New Roman, Times, Serif"></p> 224600000 4796206 1.75 4796206 2.00 8393361 737385 3000000 397524 375000 4.07 1600000 750000 4 3000000 375000 375000 <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zcPPdoySPaV3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B0_zY3Y7bslZjw6" style="display: none">Schedule of option award activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted Average Exercise Price </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weight Average remaining Contractual Term (years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Balance at April 1, 2021</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zmKwglGkGIUj" style="text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0AjFOcnP7H4" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 12pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 12pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 49%; text-align: justify"><span style="font-size: 10pt">Granted</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOpDmb7KcBb" style="width: 14%; text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">40,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> $</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zqEI9Nrlr6Ai" style="vertical-align: bottom; width: 14%; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt">3.98</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; width: 14%; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zr9Tv7lBpOR4" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zXnFj9tqiLDg" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQe0yydcIOdf" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGFttaSORoPi" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zGU7HjKKY7Sd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z0jY675dx3M8" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1077">—</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 11pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Balance at March 31, 2022</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z4jGw1alxpj" style="text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">40,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxUFV4OL3Fz6" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt">3.98</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zOhKXs5TgPck" title="Weight Average remaining Contractual Term (years)">4.83</span> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zk4mpz05vw7h" style="text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zzNsLdZB04rd" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z62DZvqNh12a" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zCtyONqkR4lk" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zToS40r9JTKj" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1lwPtY9R95e" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zPpbZjUIWUz8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zp2Pd9NJsQGk" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Exercised"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-size: 10pt">Balance at March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxcv5f3YTKg1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding ending"><span style="font-size: 10pt">40,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z1JDdpsucfTj" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Outstanding ending"><span style="font-size: 10pt">3.98</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zJWEneuOrrzl" style="font-size: 10pt" title="Weight Average remaining Contractual Term (years)">2.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vested and exercisable at March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zs7oUAEPgypj" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested and exercisable"><span style="font-size: 10pt">40,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zjAtygZMkuR2" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Vested and exercisable"><span style="font-size: 10pt">3.98</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: center"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zwtYgxrijqDf" style="font-size: 10pt" title="Weight Average remaining Contractual Term (years), Vested and exercisable">2.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 0 0 40000 3.98 0 0 0 0 0 40000 3.98 P4Y9M29D 0 0 0 0 0 0 0 0 40000 3.98 P2Y8M12D 40000 3.98 P2Y8M12D 40000 3.98 133529 <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zNCL2ldjmsq9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span id="xdx_8BF_z4RQeTKTDZrg" style="display: none">Schedule of key assumptions</span></td> <td style="padding-left: 7.1pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 73%; padding-left: 7.1pt"><span style="font-size: 10pt">Stock Price</span></td> <td style="width: 27%; padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt">$<span id="xdx_906_eus-gaap--SharePrice_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znvphghWON93" title="Stock Price">3.98</span></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Exercise Price</span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvYlMTKLbzKd" title="Exercise Price">3.98</span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Term </span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuJ05Y9bKnPc" title="Term">5</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Volatility </span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zQSRWPIvi5xl" title="Volatility">122.52</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Expected dividend yield (%)</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zrhXmh0ZPQsa" style="padding-left: 7.1pt; text-align: right" title="Expected dividend yield"><span style="font-size: 10pt">—</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.1pt"><span style="font-size: 10pt">Discount Rate (Bond Equivalent Yield)</span></td> <td style="padding-left: 7.1pt; text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_dp_c20220401__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zBIPmZ3vwOc5" title="Discount Rate (Bond Equivalent Yield)">2.28</span>%</span></td></tr> </table> 3.98 3.98 P5Y 1.2252 0 0.0228 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zL0d6cVMxuq7" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8BF_zNJLOZhbvEp5" style="display: none">Schedule of warrant activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: justify"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Number of Warrants</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weighted Average Exercise Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Weight Average remaining Contractual Term (years)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 49%; text-align: justify"><span style="font-size: 10pt">Balance at April 1, 2021</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zZQfqEjzPZy6" style="width: 14%; text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">1,939,990</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHCH7e050QM4" style="vertical-align: bottom; width: 14%; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt; color: Black">6.30</span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; width: 14%; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200401__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5P2mrSufM5b" title="Weight Average remaining Contractual Term (years)">4.62</span></span></td><td style="width: 1%; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSEw0XuYtktk" style="text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center">—</td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCPzYB0fXAFb" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">(366,892</span></td><td style="text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zo7erOYWsTo" style="vertical-align: bottom; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt; color: Black">8.08</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0X7Allt4KK1" title="Weight Average remaining Contractual Term (years) exercised">4.08</span></span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlHWkUPYQEFk" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt">  </span>—</td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4kJLsFHq5Pg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black">  </span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt">  </span>—</td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Balance at March 31, 2022</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zP4j7HR0Ja0a" style="text-align: right" title="Number of Options, Outstanding beginning"><span style="font-size: 10pt">1,573,098</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1UbfWzQ9CHi" style="vertical-align: bottom; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Outstanding beginning"><span style="font-size: 10pt; color: Black">6.64</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztlwYxMXd7q8" title="Weight Average remaining Contractual Term (years)">4.07</span></span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zehP6I99EN1i" style="text-align: right" title="Number of Options, Granted"><span style="font-size: 10pt">4,796,206</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zFYB1qkCERc4" style="vertical-align: bottom; text-align: center" title="Weighted Average Exercise Price, Granted"><span style="font-size: 10pt; color: Black">2.00</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20210401__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQpJ4Za7nIs" title="Weight Average remaining Contractual Term (years) granted">5.00</span></span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-size: 10pt">Exercised</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkdANfUQtfd9" style="text-align: right" title="Number of Options, Exercised"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt">—</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-size: 10pt">Forfeited</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zw4GagQNxR0e" style="text-align: right" title="Number of Options, Forfeited"><span style="font-size: 10pt">—</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt; color: Black"> </span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt"><span style="font-size: 10pt"> </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; font-size: 11pt; text-align: center"><span style="font-size: 10pt">—</span></td><td style="font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQSCpKUBAF3k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Expired"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQJi74Fg8XN4" style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Expired"><span style="font-size: 10pt">5.00</span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt">—</span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt"><span style="font-size: 10pt">Balance at March 31, 2023</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLmTR854x8t1" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Outstanding ending"><span style="font-size: 10pt">6,369,304</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znU0uNvMJORc" style="vertical-align: bottom; color: rgb(204,238,255); padding-bottom: 1pt; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price, Outstanding ending"><span style="font-size: 10pt; color: Black">2.7</span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2xQtz7HNv2a" title="Weight Average remaining Contractual Term (years)">4.87</span></span></td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-size: 10pt">Vested and exercisable at March 31, 2023</span></td><td style="font-size: 11pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9L00hOHsVEc" style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: right" title="Number of Options, Vested and exercisable"><span style="font-size: 10pt">6,369,304</span></td><td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-size: 11pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7LI2cuS4xV7" style="vertical-align: bottom; padding-bottom: 2.5pt; font-size: 11pt; text-align: center" title="Weighted Average Exercise Price Vested and exercisable"><span style="font-size: 10pt">2.7</span></td><td style="font-size: 11pt; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: right"><span style="font-size: 10pt"> </span></td><td style="vertical-align: bottom; padding-bottom: 2.5pt; font-size: 11pt; text-align: center"><span style="font-size: 10pt"> <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220401__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAnJikrbFd9h" title="Weight Average remaining Contractual Term (years), Vested and exercisable">4.87</span></span></td></tr> </table> <p id="xdx_8B9_zVd46FF7xHP9" style="font: 10pt Times New Roman, Times, Serif"></p> 1939990 6.30 P4Y7M13D 0 -366892 8.08 P4Y29D 0 0 1573098 6.64 P4Y25D 4796206 2.00 P5Y 0 0 0 5.00 6369304 2.7 P4Y10M13D 6369304 2.7 P4Y10M13D <p id="xdx_800_eus-gaap--OtherAssetsDisclosureTextBlock_z2AsSjMm0kXg" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 13 – <span id="xdx_827_z3zDAxdTGNUb">CONTINGENCIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">COVID-19</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The global outbreak of the novel coronavirus (COVID-19) has led to severe disruptions in general economic activities worldwide, as businesses and governments have taken broad actions to mitigate this public health crisis. In light of the uncertain and continually evolving situation relating to the spread of COVID-19, this pandemic could pose a risk to the Company. The extent to which the coronavirus may impact the Company’s business operations will depend on future developments, which are highly uncertain and cannot be predicted at this time. The Company intends to continue to monitor the global outbreak of COVID-19 and are working with our employees, suppliers and other stakeholders to mitigate the risks posed by its spread. COVID-19 is not expected to have any long-term detrimental effect on the Company’s success. Whilst restrictions associated with COVID-19 have largely been removed in our operational locations, we will continue to assess the situation, including abiding by any government-imposed restrictions, as and where relevant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Inflation </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 9pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Macroeconomic factors such as inflation, rising interest rates, governmental responses there to and possible recession caused thereby also add significant uncertainty to our operations and possible effects to the amount and type of financing available to the Company in the future.</p> <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zru9tq4MM1vg" style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 14 – <span id="xdx_82B_zICj6xgYgAW5">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company performed an evaluation of subsequent events through the date of filing of these consolidated financial statements with the SEC, and determined there were no material subsequent events which affected, or could affect, the amounts or disclosures in the consolidated financial statements.</p>